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ABSTRACT 
 
Electrochemical detection of fentanyl using screen-printed carbon electrodes with confirmatory 







 Utilizing screen-printed carbon electrodes (SPCEs), a fast, simple, and sensitive approach 
toward the detection, identification, and quasi-quantitation of fentanyl was achieved both in an 
electrochemical cell and as a drop on the electrode surface. Electro-oxidation of fentanyl at the 
electrode was demonstrated using adsorptive stripping square-wave voltammetry between -0.5 V 
and +1.6 V with 100 mM Tris-HCl buffer at pH 8.5 as supporting electrolyte. Parameter 
optimization was conducted during method development to include supporting electrolyte and pH, 
electrochemical technique, pre-treatment and equilibration time, and various surface 
modifications. The simplest method utilizing an unmodified SPCE was determined to be 
appropriate for the identification of fentanyl. Electro-oxidation of the fentanyl compound was 
observed to occur as an irreversible process due to both diffusion to the electrode surface and 
oxidation of adsorbed species on the working electrode.  
The resulting voltammograms demonstrated the presence of two oxidation peaks at 750 
mV (peak I) and 880 mV (peak II) versus a pseudo-Ag/AgCl reference. Fentanyl oxidation was 
observed at concentrations of ~76 ng/mL in cell and ~300 ng/mL in a 100 µL drop.  Statistical 
limits of detection were determined to be slightly above the observable oxidation peaks with limits 
of detection of 145 ng/mL for the cell method and 530 ng/mL for the drop method. Reproducibility 
between electrodes, assessed as the average relative standard deviation (RSD), for peak I and peak 
II in the cell was 12% and 18%, respectively. RSD in the drop was 13% and 15% for peaks I and 
II.  
Accuracy of the detection method was determined in the cell by analyzing single-blind 
samples prepared in the laboratory and demonstrated better accuracy in lower concentrations of 
fentanyl versus higher concentrations. The effects of interfering compounds were considered due 
to the likelihood of fentanyl being found in mixtures. Quinine and cocaine were found to interfere 
with peak II, while peak I remained identifiable except when present with large concentrations of 
   
 
 
interferent. Methamphetamine was observed to have a similar effect although drastically reduced 
in comparison to both quinine and cocaine. Acetaminophen and caffeine did not produce 
interfering signals. Analysis at various ratios of the compounds demonstrated that the identification 
of fentanyl could still be achieved through the presence of peak I. The oxidative mechanism of 
fentanyl was proposed based on the literature available for the oxidation of amines and 
voltammetric data present for fentanyl and related compounds. The proposed mechanism rejects 
some previously hypothesized oxidation mechanisms of tertiary amines where the presence of two 
peaks was observed. It was suggested that a two-step oxidation process of the tertiary amine 
followed by the oxidation of the newly formed secondary amine product resulted in the two 
observable peaks. However, this work agrees with literature supporting the effect of adsorption of 
the tertiary diamine to the electrode surface. This mechanism is presented herein, whereby the 
observed oxidation peaks result from the adsorbed species and the diffusion of the species to the 
electrode surface, owing to the difference in peak potentials for peak I and peak II.  
 A confirmatory LC/MS/MS method for the analysis of fentanyl and fentanyl analogs in 
oral fluid was developed and validated. Optimization of fragmentor voltage, collision energy, and 
fragmentation ions was achieved and used in the construction of a dynamic multiple reaction 
monitoring (dMRM) method. Chromatographic separation demonstrated resolution between 13 
fentanyl-related compounds along with 7 internal standards. The calibration model used was linear 
with a weighting of 1/x between the range of 0.1 ng/mL to 50 ng/mL. The limit of detection for 
the majority of drugs was determined to be 0.01 ng/mL with the limit of quantitation at the lowest 
calibrator of 0.1 ng/mL with correlation coefficients between 0.9992-0.9999. Bias, precision, 
matrix effects, recovery, and process efficiency were assessed and were within the guideline range 
for acceptability for the majority of analytes assessed using a solid-phase extraction procedure 
with spiked oral fluid. Twelve commonly encountered illicit drugs were used to assess selectivity. 
No interferences were found for fentanyl or its analogs. Stability was assessed for processed 
samples kept at room temperature in auto-sampler and the freezer, as well as, for freeze/thaw 
stability. The majority of analytes were considered stable under all conditions for up to 72 hours. 
Together these two methods demonstrate the identification and quasi-quantitation of 
fentanyl through electrochemical oxidation and confirmatory analysis via liquid chromatography-
tandem mass spectrometry (LC/MS/MS). The combined use of these techniques seeks to emulate 
the SWGDRUG requirement, although electrochemistry has, to this point, not been included in the 
list of acceptable techniques. 
 Other work contained herein demonstrates assessment of various electrode modification 
techniques to improve the signal of fentanyl, attempts at enzymatic detection of codeine and 
fentanyl utilizing cytochrome P450 isozymes 2D6 and 3A4, and electrochemical detection of the 
synthetic cannabinoid PB-22. 
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Part I: Introduction 
 2 
1.1 Problem Statement and Purpose of the Study 
 
 Opioids pose a significant threat to the health, order, and structure of society within the 
United States of America. Over the past several years, the increased use of opioids and novel 
psychoactive substances has resulted in what has been called the opioid epidemic, or the opioid 
crisis, and poses one of the most significant drug threats to the country. In response to the growing 
and staggering number of deaths, the United States Department of Health and Human Services 
declared a public health emergency.1 Although this emergency was first declared in 2017, the 
public health emergency has been continuously renewed quarterly, the latest of which was in April 
2019.2 Statistics regarding the nation’s problem with opioids are overwhelming. It is estimated 
that over 130 people died every day from a drug overdose related to opioids in 2017 and 2018. Of 
the over 47,000 deaths, 15,000 were due to heroin while over 28,000 were attributed to synthetic 
opioids. On top of this problem, the misuse of prescription opioids has only exacerbated the 
problem. In 2016, over 11 million people misused prescription opioids contributing to their 
estimated involvement in opioid overdoses of 40%.1,3 
 This problem has ravaged the country, making it difficult to find an area that has not been 
affected by the opioid epidemic. However, West Virginia has suffered dramatically as the crisis 
has continued to unfold. In February 2018, as the struggle to curb the epidemic continued, West 
Virginia Governor, Jim Justice, requested the aid of the National Guard to combat the opioid 
problem. Justice stated that there is a “terrible drug epidemic,” and said, “If we don’t [stop the 
epidemic] it will cannibalize us.”4 In both 2016 and 2017, West Virginia had the highest per-capita 
drug overdose rate in the United States, growing from 52 to 57.8 deaths per 100,000 people. The 
difference between the second-highest state (Ohio) and West Virginia was greater than 10 deaths 
per 100,000.5 The opioid problem has been prevalent in West Virginia for many years. In 2012, 
96-143 prescription opioids were prescribed per 100 people and heroin use between 2014 and 2015 
was higher than the national average.6 While the state, and country as a whole, struggle with heroin 
and prescription opioids, these more recognizable drugs have been overshadowed by the 
significant rise in novel psychoactive substances (NPSs).  
 NPSs are synthetic analogs of controlled substances that elicit a similar or heightened 
response compared to their controlled substance counterparts. These NPSs are prominent 
throughout a variety of drug classes including opioids, cannabinoids, and cathinones.7 NPSs are 
generally designed and synthesized by utilizing a core structure or another compound and making 
        Chapter 1: Purpose of Research and Objectives 
3 
 
modifications to the core structure or compound. Among these NPSs, recent years have seen 
significant increases in fentanyl and fentanyl-related compounds, including many overdose deaths 
relating to these compounds. Due to the potency of fentanyl (~ 100 times more potent than 
morphine), fentanyl analogs (a category of NPSs) pose a significant threat to the country.8 In 2016, 
15 different fentanyl and fentanyl-like substances were seized by the DEA. Of these 15 substances, 
9 (60%) were reported for the first time.9 The appearance of new drug entities has not been an 
uncommon trend in recent years. In fact, due to the possible modifications of the core structure of 
fentanyl, it is estimated that there are approximately 2,000 potential fentanyl derivatives (Figure 
1).8 These synthetic opioids (fentanyl analogs) have factored into the statistics mentioned above, 
resulting in a 107% increase in synthetic opioid-involved overdose deaths in West Virginia 
between 2015 and 2016.10 
 The existence of a large number of isomeric forms poses many challenges for both the 
forensic science community and for the legal system as a result of the many modifications possible. 
First, due to the recent and ever-expanding discovery of new synthetic drugs, presumptive tests 
are either nonexistent, lack specificity, or are not safe as the drugs have to be handled with care.9 
Scientific knowledge must be continuously updated regarding these compounds as more are 
discovered. The frequent incorporation of new entities into the illegal drug market often results in 
the lack of information concerning the testing and analysis of samples. Second, fentanyl analogs 
are generally found either as adulterants in low concentration and complex mixtures or in low 
purity.9 These compounds are commonly present in samples of heroin or cocaine to increase the 
effects of the drug.5 Lastly, there is a need for more research regarding the detection of these 
analogs for improved structure verification and identification.9 Current methods for achieving 
these identifications involve confirmatory analysis techniques that are complex, time-consuming, 
and expensive. Traditionally, chromatographic separation with mass spectrometry has been the 
analytical technique for confirmatory analysis in forensic laboratories because it provides excellent 
sensitivity and selectivity for differentiating multiple drugs simultaneously. However, there is a 
need for techniques that can minimize sample preparation, be performed outside of the laboratory 
setting, and can provide results quickly.  
  An analysis technique of this type would lend itself well toward a fast, qualitative analysis 
of drugs in the field with quasi-quantitative data, as well as, rapid analysis of samples and/or 
drivers for crime scene or driving under the influence of drugs (DUID) scenarios. Crime scene and 
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DUID scenarios serve as useful models due to the need for immediate results that can provide 
information for officer and personnel safety, investigative leads, and cause for arrest. Furthermore, 
DUID cases could benefit from noninvasive collections of oral fluid at the scene, providing 
information about recent drug use and minimal time between collection and testing. The use of 
electrochemistry holds great promise for these types of applications due to the sensitivity, 
portability, low cost, and simplicity of instrumentation inherent in electrochemical 
methodologies,12 in addition to the use of disposable testing substrates preventing contamination. 
This type of methodology would prove useful in enhancing the forensic toxicology and seized drug 
workflow to reduce backlogs and cost, as well as, to speed up screening. The use of 
electrochemical methods for the analysis of drugs has been the topic of considerable interest to 
exploit the abovementioned qualities. The detection of drugs such as cannabis,13 lysergic acid 
diethylamide (LSD),14 cocaine,15–17 synthetic cathinones,18 codeine,19 and heroin20 have been 
suggested. As such, electrochemical analysis offers a versatile platform that is currently not used 
to its full potential for detecting a wide array of substances. 































Replace nitrogen atom with carbon 
Replace benzene ring for aromatic 
substitutions or non-aromatic groups 
Substitution onto piperidine ring 
at 2,3, or 4 position 
Replace substituent of nitrogen atom or 
nitrogen replacement by oxygen, sulfur, 
or carbon. 
Substituent differences for the first and 
second position of the ethylene group 
Fusion of propionylanilido group to the 
ortho-position of anilido phenyl ring 
Carbonyl replaced for thiocarbonyl 
or methylene group 
Propionyl group replacement by other 
acyl substituents 
Substituents on benzene ring or replace 
ring with other heterocyclic groups 
Open-chain structures synthesis or 
replacement of piperidine ring for 
pyrrolidine, azepine, and other 
heterocyclic rings 
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1.2 Goals and Objectives 
 
 This study hypothesizes that the electrochemical oxidation/reduction process of opioids 
and novel psychoactive substances, including fentanyl and fentanyl analogs, is possible and will 
offer opportunities for rapid detection, identification, and field analysis. For this method to be 
relevant, accurate, qualitative information about the identification of a substance or sample must 
be acquired. The developed methodology should be capable of providing qualitative and quasi-
quantitative information about fentanyl alone and in the presence of other substances. 
 The development and testing of the electrochemical detection of fentanyl is presented in 
Part II of this thesis as a rapid and portable method. This method represents a simple, sensitive, 
and straightforward approach toward the analysis of the target analyte. Validation of the method, 
including figures of merit, is presented in chapter 3 of Part II along with the proposed electro-
oxidative mechanism for fentanyl under the methodology. 
A confirmatory analysis method is proposed in Part III of this thesis utilizing liquid 
chromatography-tandem mass spectrometry for analysis of a suite of fentanyl and fentanyl analogs. 
The chosen matrix for this work was oral fluid to allow for applications in cases involving DUID. 
This matrix allows for non-invasive sampling and provides information about recent drug use. 
Chapters 2 and 3 of Part III outline the development, optimization, and validation of the 
confirmatory method in oral fluid according to the American Academy of Forensic Science 
Standards Board (ASB) following Standard 036.  
The main objective of this study was to develop an electrochemical testing method for the 
identification of fentanyl, as well as, a confirmatory method for identifying fentanyl and its analogs 
in oral fluid using LC/MS/MS. This goal was achieved through the completion of the following 
sub-objectives: 
 
1. Development of a rapid and straightforward electrochemical method that could be used in 
the field rather than in the laboratory. 
2. Optimization of electro-analytical parameters to achieve optimal detection of fentanyl 
under seized drug case scenarios. 
3. Adaptation of the analytical method to provide both qualitative and quasi-quantitative data 
for the identification of fentanyl.  
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4. Validation of the analytical method, including the assessment of interfering compounds at 
various ratios. 
5. Implementation of an extraction procedure in oral fluid for LC/MS/MS analysis.  
6. Development and validation of a confirmatory analysis method with LC/MS/MS of oral 
fluid samples for an extended group of fentanyl analogs containing: 
a. 2’-fluoro ortho-Fluorofentanyl 
b. 4-ANPP (Despropionyl fentanyl) 
c. Acetyl fentanyl 
d. Acryl fentanyl 
e. Carfentanil 
f. Despropionyl para-Fluorofentanyl 
g. Fentanyl 
h. Furanyl fentanyl 
i. Methoxyacetyl fentanyl 
j. Norfentanyl 
k. para-Fluroisobutyryl fentanyl 
l. U-47700 
m. Valeryl fentanyl 
 














Lastly, Part IV outlines and summarizes the principal conclusions of the overall thesis and 
reiterates findings of both the electrochemical detection of fentanyl and the LC/MS/MS method 
for the suite of fentanyl and fentanyl-like substances, while Part V of this document demonstrates 
various other electrochemical approaches toward the detection of codeine, fentanyl, and PB-22 
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For hundreds of years, people have been using natural opioids for their medicinal and 
psychological properties. Natural opioids, such as morphine, are derived from the poppy Papaver 
somniferum and have traditionally been referred to as narcotics.21 Although this term is still 
sometimes used, the terms opiates and opioids have become more commonplace, with “opioids” 
commonly being used to refer to all drugs within this class. This class of drugs contains the natural 
opioids, as well as, semi-synthetic opioids such as oxycodone, heroin, and hydrocodone which are 
derived from the natural opiates, and synthetic opioids manufactured entirely in the laboratory to 
mimic the effects of opioids.21  
Although currently causing many problems in society, opioids are an especially useful tool 
in the medical field for pain relief22 and sedation.21 These drugs owe their effects to their ability to 
interact with the opioid receptors in the body and the brain to decrease the body’s response to pain. 
However, these drugs also produce a euphoric effect23 in users and high physical and psychological 
dependence, which is responsible for their current use and abuse in society. 
 
1.2 Opioid Metabolism 
 
 The majority of substances that enter the human body must eventually be excreted from 
the system. Xenobiotics, including opioids, must undergo the process of metabolism within the 
body. The metabolic process is the pathway for the biotransformation of drugs within the body, 
resulting in alterations from their original state.22 The metabolic process is of great importance and 
interest to many parties, including researchers and pharmaceutical companies who can target 
specific chemical conversions within the body for their products.  
 Although the body performs metabolic processes with the intent of removing the 
xenobiotic, the results of metabolism can be unwanted. The metabolism of some opioids can result 
in the production of active metabolites that possess properties sometimes to a higher degree than 
the pre-metabolized drug.22 The opioid metabolic process, and for most drugs, begins with first-
pass metabolism, consisting of phase I and phase II metabolism. First-pass metabolism takes place 
in the liver, generally before the circulation of a drug throughout the body.22 Phase I results in the 
chemical modification of the opioid that includes N—, O—, S— dealkylation; aromatic, aliphatic, 
or N— hydroxylation; N— oxidation; sulfoxidation; deamination; and dehalogenation.22 These 
processes occur through a general class of enzymes called cytochrome P450s. Opioids are 
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primarily metabolized by two cytochrome isozymes, CYP3A4 and CYP2D6.22 CYP3A4 has been 
demonstrated to be the primary cytochrome P450 enzyme responsible for the metabolism of 
fentanyl through N—dealkylation to norfentanyl.24,25 Phase II metabolism consists of a process by 
which drugs are made more hydrophilic, referred to as glucuronidation, which serves to allow the 
drugs to be easily excreted by the body.22 
 
1.3 Fentanyl and Fentanyl Analogs 
 
 Fentanyl, a basic compound, is considered a synthetic opioid and has been used in medical 
practice for surgical anesthesia since 196326 and for the treatment of pain,11 especially for 
individuals with advanced cancer.27 Fentanyl can produce symptoms ranging from respiratory 
depression and seizures to comas26 to causing death at amounts as low as 2 mg.28 Fentanyl is 
commonly administered intravenously, subcutaneously, or through transdermal patches.27 This 
drug poses a real risk to society due to its potency which is approximately 100 times that of 
morphine.8 The half-life of fentanyl is approximately 3-4 hours with 85% being excreted within 4 
days through the urine as fentanyl or its metabolites of norfentanyl, hydroxynorfentanyl, 
hydroxyfentanyl,26 and despropionylfentanyl (4-ANPP).29  
 Fentanyl was first synthesized by Paul Janssen and has since been extensively studied with 
various synthetic approaches and changes to the structure to produce derivatives of fentanyl.11 The 
main structural components of fentanyl include an amide group, aniline ring, piperidine ring, and 




Figure 2: Fentanyl structure demonstrating scaffold regions as locations for modifications. 29 (adapted 
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 As seen in Figure 2 above, there are many areas throughout the fentanyl structure allowing 
for modification and the development of a multitude of fentanyl analogs. Fentanyl acts through an 
affinity for the µ-opioid receptors.11 Analog compounds are those compounds that illicit a similar 
or heightened response when compared to their parent molecule. One such fentanyl analog, 
carfentanil, has demonstrated heightened potency and is considered to be approximately 10,000 
times more potent than morphine.8,11 Since approximately 2009, the number of newly reported 
novel psychoactive substances has increased drastically from previous years.8 Part of this increase 
can be attributed to the rise of these fentanyl analogs. As mentioned previously, due to the many 
locations within the fentanyl structure, it has been hypothesized that there are approximately 2,000 
possible fentanyl analogs.8 
 Several groups have published data regarding the electrochemistry of fentanyl. These 
studies are summarized in brief within the table below (Table 1). 
 




 Electrochemistry refers to the study of the interactions between electricity and chemical 
changes. Many areas of chemistry utilize electrochemical concepts including synthesis, kinetics, 
nerve impulses, electron transport, and thermodynamics, among others.36 A specific type of 
chemical reaction, termed an oxidation-reduction (Redox) reaction, describes a chemical change 
Electrode Technique LOD  (µg/mL) 
Linear Range 
(µg/mL) R
2 RSD (%) Reference 
       
GCM-OPFP CV/ Electrochemi-luminescence 0.003 0.003 to 33.6 0.9994 
1.9 at 1.7 
µg/mL 
30 
Graphite SPE HPLC-AD 0.77 10 to 120 0.999 0.53 31 
Hg ASV 0.017 0.336 to 0.034 0.9992 3.6 32 
SPCE-RTIL CSWV 1.7 1.7 to 32 0.997 -- 33 
fSPCE-MWCNT/ 
RTIL SWV 3.4 3.4 to 33.6 0.992 3.2 
34 
SPCE AdS-SWV 0.075 0.075 to 0.64 1.3 to 6.9 
0.9948 
0.9909 12 This work 
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resulting from the movement of electrons within a system. Redox reactions are characterized by 
the gain of electrons by one species (reduction) and the loss of electrons by another species 
(oxidation). Equation 1 demonstrates a simple example of a redox reaction: 
 
! + #$ ⇌ &        (1) 
 
where	! represents the oxidized species, #$ represents the number of electrons involved in the 
reaction, and & represents the reduced species. 
Electro-analytical measurements generally involve the measurement of current resulting 
from a chemical change, referred to as Faraday’s Law. The use of Faraday’s Law, the application 
of a Faradaic process, provides a relationship by which the concentration of the analyte in solution 
can be determined based on the amount of current flowing:  
 
( = *+,      (2) 
 
where Q is the charge, n is the number of electrons in the reaction, F is Faraday’s constant (96,485 
C/mol), and N is the number of moles electrolyzed in the reaction. Through differentiating 





                 (3) 
 
where i is the current, and dN/dt is the change in moles over the change in time.36 
 Electrochemistry is a mature analytical technique that has proven to be a versatile platform 
for analysis. Owing to this versatility is the variety of techniques and methods available, whose 
parameters of potential (E), current (I), charge (Q), and time (t) can be measured or controlled to 
provide the required information about the analyte in solution. Aside from the variety of methods, 
electrochemistry offers high sensitivity, accuracy, precision,37 and selectivity. For example, low 
detection limits are often possible with picomole analysis in some cases.36 
 However, to utilize electrochemistry for analytical purposes, the analyte of interest must 
be electroactive. Electroactivity can be thought of as the ability of a species to alter its oxidation 
state as a result of potential being applied. This redox process can be accomplished either through 
the innate properties of the analyte, employing a method to generate an electroactive species based 
on the analyte, or sensing the species indirectly with another electroactive mechanism. This idea 
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results in one way to gain selectivity in electrochemical measurements. Standard reduction 





 Typically, electroanalytical techniques employ methods that utilize a potentiostat and three 
electrodes: the working electrode, the auxiliary/counter electrode, and the reference electrode. The 
potentiostat serves to control the potentials applied to the electrodes and also measures the 
resulting current within the chemical system, accomplished through the use of the three electrodes 
mentioned previously.  
 The working electrode serves as the location where the redox reaction of interest will take 
place. Working electrodes can be made of many different materials such as carbon, indium tin 
oxide (ITO), mercury,12 gold, platinum, etc. The choice of working electrode construction is 
tailored to the application of the investigator or the chosen technique. Working electrodes 
generally are inert materials with good conductivity and wide potential windows.36 The auxiliary 
electrode serves as the location of the complementary redox process to the working electrode.12 
The auxiliary electrode is typically a non-polarizable metal such as platinum or palladium that 
allows current to flow freely across the electrode-electrolyte interface. Finally, the reference 
electrode serves to provide a constant potential from which the applied potential to the chemical 
system can be monitored and measured.12 These electrodes require a stable, highly reproducible 
and reversible half-cell potential and reaction.36 The most common form of reference electrode 
found today consists of silver-silver chloride (Ag/AgCl). Variations of these three types of 
electrodes allow for versatility in analysis procedures, sensitivity, and selectivity. 
 Traditionally, the field of electrochemistry has employed what is termed the conventional 
electrochemical cell (Figure 3). This type of system generally employs the three electrodes 
mentioned above, which are relatively large and cumbersome. While traditional electrodes can 
often provide very sensitive measurements, they usually require extensive cleaning and treatment 
between uses. Furthermore, the typical electrochemical cell requires large sample volumes for the 
electrodes to be immersed in the supporting electrolyte. Some limitations presented by the 
conventional electrochemical set-up have been addressed by the development of screen-printed 
electrodes (SPE). These electrodes encompass the three conventionally electrodes within a single 
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platform that has a small footprint (Figure 3). Although SPEs can be manufactured using a variety 
of materials, a common form is the screen-printed carbon electrode (SPCE). SPCEs have many 
advantages over the traditional methods due to their small size including low cost, robustness, and 
disposability.38 Small volumes can be analyzed, leading to their use in analytical methods where 
large samples cannot be obtained or would be inappropriate/impractical. SPCEs also have good 
reproducibility between electrodes, allowing them to be disposable due to inexpensive 
manufacturing. Finally, the carbon substrate for the working electrode allows for many 
modifications and changes to be incorporated during or after the manufacturing process, 
supporting a wide range of applications. The small size of these electrodes makes them excellent 
candidates for point-of-care devices and sensors. 
 
Figure 3: Cell set-up utilizing conventional electrodes with an approximate height of 15 cm (left) and 
screen-printed carbon electrodes used in this work with an approximate size of 3.5 cm x 1.5 cm 
demonstrating use in cell or with a drop (right). 
 
1.4.2 Voltammetric Techniques 
 
Voltammetric techniques are of great importance and extensive use since they utilize a 
changing potential at a rate relative to the reference electrode and measure the resulting current 
between the working and reference electrodes termed a dynamic electroanalytical technique.36 
Additionally, these methods can provide both qualitative and quantitative information about the 
species in solution. The resulting plot, termed a voltammogram, plots the current against the 
potential. Voltammetry is considered an active technique and has many parameters that can be 
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 Cyclic voltammetry (CV) is a commonly encountered voltammetric technique. CV utilizes 
a changing potential that is swept either in the positive or negative direction and then reversed and 
swept back in the other direction. Typically, this is a stationary technique where the solution is 
non-stirred (quiescent) and movement in solution is defined by diffusion.36 In this way, both 
reduction and oxidation processes can be observed that can provide the identification and 
characterization of an analyte. Due to the ability to quickly analyze a wide potential range, CV is 
often the first technique used during the investigation of an analyte.36 This approach can elucidate 
the electrochemical behavior of the analyte. CV operates through the use of a linearly changing 
potential. Figure 4 demonstrates an example of a cyclic voltammogram and the theoretical 




Figure 4: Cyclic voltammogram for fentanyl at 1.46 mM (left) and waveform demonstrating the cyclic 
nature of the potential applied (right). 
 
 Two different pulse voltammetry techniques are commonly used in the analysis of species 
with electrochemistry: differential pulse voltammetry and square-wave voltammetry. These 
techniques rely on the pulsing of potentials to gain information about the analyte in solution. In 
summary, the potential is quickly increased to a value, held for a short time, and then dropped 
again. This process repeats with increasing potential, resulting in the probing across a potential 
range.36 These techniques are commonly used when low detection limits are desirable or required. 
Measurement of the current within the system occurs toward the end of each pulse, allowing the 
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 Differential pulse voltammetry (DPV) utilizes the pulse technique in a way that allows the 
potential to be scanned. Rather than dropping the potential back down to a baseline value, the 
potential drops less than the original pulse.36 In this way, the potentials of the pulse are increased 
continuously over the desired potential window. However, of interest to this study is square-wave 
voltammetry. 
 Square-wave voltammetry (SWV) is another pulse technique. As with other pulse 
techniques, SWV attempts to minimize the effect of charging current. This technique implements 
a potential waveform that can be thought of as constant incremental pulses superimposed on a 
staircase (Figure 5).36 This is to say that the pulse follows a step-wise increase in potential for both 
the forward pulse and reverse pulse. The effect of charging current is minimized through the 
sampling of current response near the end of the forward pulse and then again near the end of the 
reverse pulse. The voltammogram is then constructed by plotting the net current of the forward 
and reverse pulse, resulting in a peak.36 Utilizing SWV allows a single scan to achieve both 
oxidation and reduction (in the case of a reversible process) when the redox potential of the analyte 
falls between the potential step, allowing for the use of the net current generated. SWV is a widely 
used technique due to its ability for rapid scan rates and low limits of detection, often in the 10-7 
M to 10-8 M range. 
 
 
Figure 5: Adsorptive stripping square-wave voltammogram for fentanyl at 3.62 µg/mL (left) and waveform 
demonstrating a pulsed signal superimposed on a staircase giving the forward and reverse waves (right). 
 
Lastly, electrochemistry and voltammetry rely on the ability of the current to move 
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selection of the supporting electrolyte can be critical for the analysis being performed for several 
reasons. First, the electrolyte lowers the resistivity within the system. Low resistivity allows 
current to flow effortlessly throughout the system.36 Second, the electrolyte can minimize the effect 
of migration within the system that could affect mass transport. In order to achieve this, it is 
generally recommended that the supporting electrolyte be at a concentration approximately 100 
times the concentration of the analyte.36 Lastly, the electrolyte can have an effect on the 
electrochemical processes and can be used to influence redox potentials in order to better separate 
analyte peaks.36  
 
1.4.3 Amperometric Techniques 
 
Amperometric techniques make use of a single potential and are thus considered a potential 
step technique, where the potential is “stepped” to a particular value and then held for a certain 
amount of time.36 Therefore, the waveform for the potential applied during chronoamperometry is 
a horizontal line. The current is then measured against time while the potential is held constant. 
While chronoamperometry generally makes use of a quiescent solution, amperometric detection 
can also be achieved for a stirred system. This technique can be useful for a standard addition 
approach for quantitative analysis due to the ability to see changing current at certain times. 
Amperometric techniques are commonly encountered in methods utilizing anodic or cathodic 
stripping voltammetry. Voltammetric stripping techniques utilize a constant applied potential for 
a set period to deposit the analyte onto the working electrode surface. A subsequent voltammetric 
technique then sweeps the potential in order to strip, or remove, the analyte from the working 
electrode through the redox process. This deposition of analyte material serves as a 












Part II: Electrochemical Analysis of Fentanyl 
 18 
1.5 Forensic Electrochemistry 
 
 
 A pseudo-branch of electrochemistry, forensic electrochemistry describes the use of 
electrochemical methods and techniques to monitor response as a result of oxidation or reduction 
of an analyte relating to evidence found at the scene of a crime or used during a criminal act with 
the principle intention of providing qualitative or quantitative information.12 Electrochemistry 
proves useful in forensic applications due to its sensitivity, selectivity, low cost, and portability. 
Electrochemical techniques have already been reported for a wide range of forensic applications 
including poisons, gunshot residue, fingerprints, DNA, and drugs.12 Of interest to this thesis is 
the application of electrochemical techniques for the detection of drugs of abuse.  
 The utilization of electrochemical techniques for the detection of drugs of abuse has been 
shown in the literature. For examples, Jiang et al. reported a sensitive detection technique for 
cocaine using an “aptamer-based sandwich” along with a graphene/AuNP modified screen-printed 
carbon electrode (SPCE). The addition of multiple molecules including NADH, streptavidin-
conjugated alkaline phosphatase, and p-aminophenylphosphate, among others allowed for an assay 
format and redox-recycling that provided an estimated limit of detection of 1 nM.15 Oliveira et al. 
reported a fast, non-destructive voltammetric method for detecting cocaine. This approach utilized 
methoxy-substituted N,N'-ethylene-bis(salcylideneiminato)uranyl(VI) complexes to modify a 
carbon paste electrode along with cyclic voltammetry. The authors reported a working range of 
1.0 x 10-7 M to 1.3 x 10-6 M.16 Finally, Asturias-Arribas et al. reported cytochrome P450 2B4 
based electrochemical biosensor for the detection of cocaine with an SPCE. Covalent 
attachment of the enzyme allowed the authors to achieve direct electron transfer to the enzyme 
and provided a detection limit of 0.2 mM.17  
 Lowe et al. demonstrated that tetrahydrocannabinol could be detected utilizing an edge 
plane pyrolytic graphite electrode. This indirect detection of THC was performed at low 
potential compared to the typical 1.2 V and resulted in a limit of detection of 25 µM.13 Balbino 
et al. demonstrated the usefulness of electrochemical methods to decrease false positives. By 
utilizing a glassy carbon disk electrode and a pre-concentration step, the authors were able to 
detect ∆9-THC in the  presence of the FBB color test reagent using cyclic voltammetry and 
obtained a limit of detection and quantitation of 1 ng/mL and 3.5 ng/mL, respectively.39 
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 Merli et al. developed a method utilizing stripping voltammetry for the determination of 
lysergic acid diethylamide (LSD). Adsorptive stripping voltammetry with a glassy carbon 
electrode allowed the authors to determine the presence of LSD quantitatively. A linear range 
of 1-90 ng/L with a limit of detection of 1.4 ng/L and limit of quantitation of 4.3 ng/L were 
obtained and were comparable to LC-MS. The authors also investigated potential interfering 
species commonly administered with LSD and saw no interferences at 50 times the LSD 
concentration.14 
 Smith et al. investigated the electrochemical behavior of synthetic cathinones using 
boron-doped diamond, glassy carbon, and screen-printed graphite electrodes. The authors 
utilized (±)-methcathinone, (±)-4’-methylmethcathinone, (±)-mephedrone, and (±)-4’-methyl-
N-ethylcathinone. The authors demonstrated the electroactivity of cathinone species; however, 
problems with the selectivity of mixtures were reported.18 
 Finally, of interest to this study, several articles have been published concerning the 
electrochemical behavior of opioids. Garrido et al. investigated the oxidative behavior of heroin 
and its metabolites using differential pulse voltammetry and characterized the electrochemical 
mechanisms, proposing a new mechanism for the oxidative production of a secondary amine 
and an aldehyde from heroin.20 Asturias-Arribas et al. demonstrated the ability to utilize an 
enzyme-modified screen-printed carbon electrode for the detection of codeine. The authors used 
the CYP2D6 isozyme as the biological recognition molecule and covalently bound the enzyme 
to a modified electrode surface for direct electron transfer. A limit of detection of 4.9 µM and 
linear range of 4.9-45.4 µM was achieved. The authors also demonstrated the use of the 
technique in the analysis of spiked urine samples, as well as, the reproducibility and 
repeatability of the methodology.19 
 
1.6 Electrochemical Biosensors 
 
 Biosensors consist of an analyte-specific biological molecule. The biosensor could be an 
enzyme, antibody, receptor, etc. They also contain a transducer which allows some change to occur 
that can be monitored by a detector.40 The study of biosensors for forensic science applications is 
relatively new. Immunoassays have been the preferred choice historically for illicit drug biosensors 
and have had much success. They have been integrated into chip forms with antibody-arrays for 
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testing multiple drugs, enhancing selectivity and specificity, as well as, eliminating false-positives. 
Several commercial tests utilizing biosensors have seen cut-off levels for opiates ranging from 40 
ng/mL to 10 ng/mL.40 However, other forms of biosensors have been explored and are currently 
being investigated in more detail. 
 Electrochemical biosensors based around enzyme coupled reactions utilize the enzyme to 
either produce an electroactive species or deplete an electroactive species in such a way that an 
electrical signal can be produced.41 In addition to sensitivity, simplicity, low cost, and fast response 
time, the use of enzymes imparts another layer of selectivity toward the targeted analyte but also 
determines the lifespan of the sensor.41–44  
 The utilization of CYP biosensors has taken many forms historically. The major problem 
surrounding these studies is how to make the CYP biosensor more effective. Some have used 
NADPH as the electron mediator. However, to eliminate the need for a mediator, immobilization 
of the CYP enzyme on the electrode surface has been recently suggested. The evolution of these 
electrodes has gone through three generations, according to Putzback.41 First and second-
generation electrochemical biosensors suffered from poor electron transfer, leaching of mediators, 
interference problems, and the need for oxygen. Third generation biosensors have attempted to 
eliminate these problems, mainly by immobilizing the mediator and/or enzyme to the surface of 
the electrode. These sensors generally boast increased electron transfer efficiency, faster response 
times, and higher sensitivities.41 Further, electrode modifications can help achieve these 
characteristics and amplify them.41 
Various groups have explored different strategies including adsorption on bare electrodes, 
layer-by-layer adsorption, adsorption to thin films, the use of screen-printed electrodes, 
encapsulation in polymers or gels, covalent attachment to self-assembled monolayers, and 
nanostructured materials.45 There have been many examples of the use of CYP biosensors and 
enzymes utilizing these techniques. However, immobilization of the enzyme may cause random 
enzyme orientation resulting in a less accessible active site with less favorable electron transfer41 
or conformational changes to inactive forms.45 
Nanoparticle modifications have been a popular choice due to their ability to increase the 
number of biological molecules on the surface of the electrode.41 The choice to use nanomaterials 
is made in part because of their size-tunable properties, high surface-to-volume ratio, shape-
dependent properties, reduced energy consumptions, etc.46 Nanoparticles have been shown to 
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improve performance for biosensors due to their comparable size to biomolecules and analytes, 
and are useful in their ability to provide proper orientation, proper interfacing, to serve as 
electrodes, and to provide better electron transfer.46 These benefits demonstrate improved 
sensitivity, limit of detection, and selectivity of biosensors.46 Many groups have demonstrated the 
use of nanomaterials to stabilize the active forms of biomolecules and to immobilize these 
molecules to the electrode surface.46 
 A conventional method, due to its simplicity, is covalent attachment utilizing self-
assembled monolayers (SAMs). The use of SAMs imparts functional groups (—CH, —NH2, or 
—SH) to the surface of the electrode for the covalent attachment of the enzymes. SAMs of long 
and short size have also been utilized to increase electron transfer rates.41 Yang et al. demonstrated 
one such use through an 11-mercaptoundecanoic acid and octanethiol SAM on a gold electrode 
for the sensing of warfarin. The authors eliminated the need for cofactors and mediators and 
demonstrated the direct electron transfer between the heme group of the covalently bonded 
CYP2C9 and the gold electrode.47 Another SAM technique utilizes amine coupling. This technique 
uses a monolayer with amine groups and the addition of EDC (1-Ethyl-3-[3-dimethylaminopropyl] 
carbodiimide hydrochloride) and NHS (N-hydroxysuccinimide) to covalently bond the enzyme to 
the monolayer.45  
 
1.7. Cytochrome P450 
 
 The term Cytochrome P450 (CYP) describes a family of heme-containing enzymes that 
share a similar structure (Figure 6). Many isozymes, various forms of the CYP enzyme, have been 
discovered and studied.45 These enzymes were previously referred to as mixed-function oxidase 
enzymes. This name was based on the fact that they reside on the membranes of the endoplasmic 
reticulum within the liver and are the terminal oxidases of the mixed-function oxidase system. The 
current name represents the wavelength at which the enzymes absorb light (450 nm) with ‘p’ 
standing for the word pigment.48 CYPs play a critical role in the metabolism of many xenobiotics 
(foreign substances in the body, such as drugs). Metabolic processes mentioned earlier such as 
hydroxylation, epoxidation, and N—, S—, and O—demethylation are a result of CYP 
metabolism45 and an attempt to increase the water solubility of the drug.48 The pharmaceutical 
industry has invested much effort into the understanding of the inhibition and substrates of these 
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enzymes.45 In mammals, 18 different CYP families have been discovered, and 43 subfamilies in 
humans with 57 individual enzymes have been found. These various isozymes are denoted by a 
combination of a number-letter-number system, where the first number and letter designate the 
amino acid sequence and the final number is the enzyme discovery number (i.e., CYP3A4).48 Of 




Figure 6: Heme (iron protoporphyrin IX) group.49 
 
These CYP enzymes follow a typical catalytic cycle (Figure 7) due to the presence of the 
heme group, resulting in a two-electron reduction of the enzyme. Upon entering the active site of 
the enzyme, the substrate displaces the bound water50 inducing a high-spin Fe3+ from the low-spin 
resting state (although the spin shift is not always needed in all systems).51 This results in an out 
of plane iron by 0.3 Å and a pentacoordinate heme iron (a).51 A more positive reduction potential 
results, allowing for electron transfer, and the ferric enzyme is reduced to a ferrous state (b).50 
Oxygen then binds resulting in the ferric state and a low-spin hexacoordinated iron (c).51 Further 
reduction of the complex results in a peroxo-intermediate (d) followed by the protonation to a 
hydroperoxo-intermediate (e).50 A second protonation with heterolysis results in an oxoferryl 
species (highly reactive) (f).51 A substrate radical is then formed by the loss of substrate hydrogen 
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to the oxoferryl species (g), which hydroxylates the substrate through radical rebound, resulting in 
its release from the enzyme and the low spin state of the enzyme (h).51  
 
 
Figure 7: Catalytic cycle of a generic CYP enzyme.51 (Adapted from Gilardi and Nardo) 
 
The 2D6 isozyme is responsible for the metabolism of approximately 25% of drugs 
prescribed such as antidepressants, antipsychotics, and antiarrhythmic, and is highly polymorphic 
within humans.52  Regarding opioids, CYP2D6 has been implicated in interactions with codeine, 









Part II: Electrochemical Analysis of Fentanyl 
 24 
 
Figure 8: CYP2D6 enzyme ribbon diagram.54 
 
The 3A4 isozyme is the most prevalent CYP enzyme in the liver (39%) and within the 
small intestine (82%).55 This enzyme metabolizes over 120 medications on the market.48 In terms 
of opioids, CYP3A4 has been implicated in interactions with alfentanil, buprenorphine, codeine, 
dihydrocodeine, fentanyl, hydrocodone, methadone, oxycodone, and sufentanil.56 
 
 
Figure 9: CYP3A4 enzyme ribbon diagram.57 
 
1.8. Nanomaterials and Electrode Modifications 
 
 The field involving nanotechnology and nanoscale modifications has grown extensively, 
and this includes the use of nanomaterial modifications in electrochemistry. Electrochemistry has 
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seen a wide variety of nanomaterial modifications including metal nanoparticles (NPs), carbon-
based materials such as carbon nanotubes, enzymes, and self-assembled monolayers. These many 
modification techniques have been explored due to the ability of nanomaterials to improve 
response, biocompatibility, conductivity, and catalytic activity,43 as well as, the ability to control 
the size and structure.58,59 
Nanoparticles are generally considered to be between 1 and 100 nm particles.42 Metal 
nanoparticles are commonly encountered modification techniques in electrochemistry for many 
reasons. Metal NPs may be used as a method for enhancing the sensitivity of the detection method 
as they can provide bonding sites for some analytes60 and improve the electron transfer process.58 
Furthermore, the use of nanoparticles on the surface of electrodes can significantly increase the 
surface area42,61 and improve interactions with enzymes.62 Metal NPs are also generally low cost,42 
easy to immobilize on the surface of electrodes, and have high strength and chemical stability.63 
Several different metals have been used for the development of nanoparticle and metal 
modifications including gold, silver, platinum, rhodium, and palladium.64   
Other commonly encountered nanomaterials are carbon-based, such as single-walled 
carbon nanotubes (SWCNTs) and multi-walled carbon nanotubes (MWCNTs), as well as, 
graphene. These carbon structures boast high surface-area-to-volume ratios, demonstrate excellent 
electron transport properties over distances,58 and may act as semi-conductors or metallic 
conductors due to sp2 hybridization.41 SWCNTs can be thought of as a single tube-like structure 
formed by graphene sheets,41 while MWCNTs are an array of these structures.58 The drawbacks 
of using carbon nanotubes include some difficulty in manipulation and functionalization.41 
Another frequently utilized modification technique is the production of self-assembled 
monolayers (SAMs). The technique of using SAMs involves the generation of some molecular 
layer forming on the surface of the electrode. The formation of the monolayers can be achieved on 
a variety of electrode surfaces and provide a variety of functional groups based on the SAM 
molecule, such as —CN, —NH2, and —SH.41 The use of SAMs can be tailored to the required 
need and use single, multiple, or different sized molecules to achieve the desired effect and attempt 
to minimize possible problems due to the typically encountered dense monolayer formation.41  
Many other electrode modification techniques are available and even more combinations 
of the above-mentioned modifications. However, these are outside the scope of this thesis.  
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1.9. Method Validation for Qualitative Identification and Screening 
 
 The ASB has designated method validation guidelines concerning forensic toxicology 
methods. Validation ensures that a method meets the specified criteria for acceptance according to 
its fit for purpose. The parameters designated by ASB for validation provide an objective approach 
to evaluating a methodology.65 The purpose of developing the electrochemical detection method 
for fentanyl in this study was to provide the qualitative identification of fentanyl along with quasi-
quantitative data. The ASB has denoted guidelines based on the intent of the method under 
question (i.e., screening, qualitative, or quantitative). The required validation parameters for 
screening and qualitative methods are considered to be the limit of detection, interference studies, 
and carryover. When applicable ionization suppression/enhancement, dilution integrity, and 
processed sample stability should also be assessed.65 
 
1.9.1. Carryover and Interference Studies 
 
 Carryover refers to a previous sample affecting the analysis of a subsequent sample. Due 
to the nature of the electrochemical measurements made in this study and the use of disposable 
screen-printed electrodes, the assessment of carryover was not performed. However, interference 
studies refer to the effects of matrix and other analytes on the detection capability and reliability 
of the method. Interferences must not affect the ability of the method to reliably identify the analyte 
of interest. ASB recommends that commonly encountered drugs be assessed when performing 
interference studies, as well as, drugs that are similar to the analyte.65 
 
1.9.2. Limit of Detection (LOD) 
 
 ASB Standard 036 requires the assessment of the LOD for all types of methods and 
provides multiple approaches for its estimation.65 Two forms of LOD estimation are acceptable 
for the electrochemical analysis carried out in this study: estimation using the lowest non-zero 
calibrator and estimation using a linear calibration curve. Both methods imply the analysis of 
calibration curves by the methodology. The former may serve as a more conservative approach to 
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determining LOD of a qualitative method as a positive signal must be seen and tested, while the 
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Fentanyl citrate was purchased from Cayman Chemical Company (Ann Arbor, MI). 
Acetaminophen was purchased from Sigma-Aldrich (St. Louis, MO). Methamphetamine, cocaine 
hydrochloride, quinine, acetaminophen, and caffeine were used for interference studies. Methanol 
(Optimaâ) and concentrated Hydrochloric acid (Trace grade) were purchased from Fisher 
Scientific (Fair Lawn, NJ). Tris(hydroxymethyl)amino-methane, Monobasic sodium phosphate, 
dibasic sodium phosphate, sodium hydroxide, and potassium chloride were purchased from Sigma-
Aldrich (St. Louis, MO). A Millipore Direct-Qâ UV water purification system (Billerica, MA) 
was used to obtain purified water (18.2 MW).  
 
Screen-printed carbon electrodes were obtained from the Universidad de Burgos analytical 
chemistry department. SPCEs were fabricated using a DEK 248 screen-printing system (DEK, 
Weymouth, UK) with polyester screens with stencils. SPCEs contained conductive silver tracks, 




Electrochemical measurements were acquired using the PalmSens3 and PalmSens4 
potentiostats with PSTrace software (Randhoeve, Netherlands). The pH of buffer solutions was 
determined using a FiveEasy Plus pH meter by Mettler-Toledo (Columbus, OH).  
 
2.3 Preparation of Standard Working Solution 
 
A Fentanyl stock solution was prepared from fentanyl citrate for a final concentration of 
3182 µg/mL for use in preparing subsequent concentrations for electrochemical analysis. 
 
2.4 Manufacture of Screen-Printed Carbon Electrodes 
 
 SPCEs were provided by our colleagues in Burgos, Spain. A DEK 248 screen-printing 
system (Weymouth, UK) was used to manufacture the SPCEs. The sequential deposition of the 
appropriate inks was performed using a series of polyester screen stencils. The following layers 
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were prepared: silver conductive tracks, Ag/AgCl pseudo-reference electrode, carbon counter 
electrode, carbon working electrode (0.126 cm2), and an insulating layer.  
 
2.5 Electrochemical Measurements 
 
Voltammetric measurements were performed in phosphate-buffered saline (50 mM) 
supplemented with 100 mM KCl or NaNO3 (PBS) and Tris-HCl (100 mM pH 8.5) as supporting 
electrolytes.  
Cyclic voltammetry (CV) was performed to determine the electroactivity of fentanyl in 
PBS by analyzing increasing concentrations of fentanyl in a 5 mL electrochemical cell containing 
PBS pH 7.4 supplemented with chloride and another supplemented with nitrate. Voltammetric 
measurements were carried out between -0.5 V and 1.6 V (vs. SPE Ag/AgCl). 
Parameter optimization was conducted for pH, supporting electrolyte, technique 
parameters, stirred equilibration time, and amperometric pre-treatment. Fentanyl was prepared to 
a concentration of 152 µg/mL in pH 5.5, 6.0, 6.5, 7.0, 7.4, 8.0, 8.5, and 9.0. The above CV 
parameters were used to analyze a 100 µL drop of each solution on the SPCE surface. Peak currents 
were monitored for oxidation peak I (0.75 V) and peak II (0.88 V). Square-wave voltammetry and 
differential pulse voltammetry were tested. Technique parameters were optimized to provide a 
maximum current response. PBS (pH 8.5) and Tris-HCl (pH 8.5) were analyzed in the 
electrochemical cell through increasing concentrations of fentanyl to determine the optimal 
supporting electrolyte. The effect of equilibration time on current response was analyzed for times 
0, 10, 20, 40, 80, 160, 320, 640, and 1280 seconds at a fentanyl concentration of 336 ng/mL in the 
electrochemical cell. Finally, anodic pre-treatment of the carbon surface was assessed to improve 
the current response. The potentials applied ranged between 1.0 and 1.6 V at times between 20 and 
80 seconds.  
Adsorptive stripping square-wave voltammetry of fentanyl and interfering drugs was 
conducted through the initial application of an anodic pre-treatment at 1.5 V for 40 seconds in 
Tris-HCl followed by a 320 second equilibration time to allow for adsorption. Analysis of analytes 
was accomplished through SWV between -0.5 V and 1.6 V with a potential step (Estep) of 0.012 
V, an amplitude of 0.075 V, and a frequency of 100 Hz either in a 5 mL electrochemical cell or 
100 µL drop. An equilibration time of 320 seconds was used for analysis. To this end, increasing 
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concentrations of analyte were used for analysis in the cell, and individual solutions were used for 
analysis in drop. Calibration curves were constructed and assessed for linearity and reproducibility 
through relative standard deviation (RSD). 
Interference studies were conducted on methamphetamine, caffeine, cocaine, 
acetaminophen, and quinine. The standard addition method with SWV procedure was used for the 
cell to determine any interfering species. Methamphetamine was analyzed between 149 ng/mL and 
33.5 µg/mL, caffeine between 193 ng/mL and 50.1 µg/mL, cocaine between 303 ng/mL and 13.4 
µg/mL, acetaminophen between 151 ng/mL and 13.8 µg/mL, and quinine between 99 ng/mL and 
9 µg/mL. Fentanyl mixtures with cocaine, quinine, and acetaminophen were assessed for the 
following ratios: 0.3:10 µg/mL, 1:10 µg/mL, and 1:3 µg/mL. A mixture between fentanyl and 
methamphetamine was assessed for the following ratios: 0.3:10 µg/mL, 0.3:20 µg/mL, and 1:3 
µg/mL.  
An anodic stripping voltammetric approach was performed using an anodic pre-
concentration step, followed by the optimized square-wave procedure. Pre-concentration was 
achieved through the application of 0.1 V for 120 seconds. These parameters were optimized by 
varying the times and potentials to assess peak current and peak shape. During pre-concentration, 
the solution was stirred when performed in a cell with Tris-HCl. Prior to the application of the 
SWV method, the stirring was turned off to allow for a quiescent solution during SWV. Calibration 




 Validation was achieved through the completion of the above-mentioned tasks to determine 
the limits of detection and any interfering compounds that could affect detection. The limit of 
detection was calculated based on the mean and the standard deviation of the y-intercept through 
the application of equation 4: 
 
1!2 = 3 ×
56
7
      (4) 
 
where 89  is the standard deviation of the y-intercept and : is the average slope. 
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2.7 Electrode Modification Techniques 
 
 The following modification techniques were performed on SPCEs for an investigation into 
their ability to improve the signal for fentanyl in order to achieve lower limits of detection. 
 
2.7.1 Silver Nanoparticles 
 
 Two varying concentrations of silver nitrate were investigated for use: 0.1 mM silver 
nitrate and 5 mM silver nitrate. Concentrations were prepared in Britton-Robinson buffer pH 2.0. 
Deposition of the nanoparticles on the carbon working electrode was achieved through the 
application of -0.12 V for varying amounts of time to control the deposition process. The silver 
solution was stored protected from light. 
 
2.7.2 Gold Nanoparticles 
 
 Gold chloride trihydrate was used to make 1 mM solutions in 0.5 M sulfuric acid. 
Deposition of gold nanoparticles onto the carbon working electrode was achieved through 
amperometric means by the application of 0.18 V. Deposition of gold nanoparticles onto a gold 
working electrode surface was achieved through the amperometric application of -0.4 V. In both 
instances the deposition time was varied to control the amount of gold deposited onto the surface 
of the electrode.  
 
2.7.3 Rhodium Nanoparticles 
 
 Rhodium nanoparticles were deposited onto the carbon working electrode surface using a 
solution of 0.1 mM Rhodium (III) chloride crystals in 0.5 M sulfuric acid. The deposition was 
achieved through the application of -0.25 V for 480 seconds. Again, a variation of both the time 
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2.7.4 Multiwalled Carbon Nanotubes 
 
  A solution of 3 mg/mL of MWCNTs in DMF was prepared. The solution was allowed to 
sonicate for approximately 1 hour to remove aggregates. A small volume of the solution was placed 
onto the working electrode, being careful to keep the solution only on the w.e., and then allowed 
to dry before use. 
 
2.7.5 Graphene Oxide 
 
 The desired concentration of graphene oxide was prepared from an aqueous solution of 
graphene oxide. This solution was placed on the working electrode and allowed to dry. Reduction 
of the graphene oxide surface was achieved by cyclic voltammetry in 0.1 M potassium nitrate 
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3.1 Electrochemical Behavior of Fentanyl 
 
 
In order to demonstrate the electroactivity of fentanyl within a cell, cyclic voltammetry 
was performed between -0.5 V and 1.6 V. Cyclic voltammetry of fentanyl in PBS buffer 
demonstrated a broad oxidative peak between 0.8 V and 1.2 V (Figure 10). The lack of reduction 
peaks suggests that there was a non-reversible electron transfer taking place. As the fentanyl 
concentration was increased, it became apparent that two oxidative peaks were present, possibly 
suggesting two separate electron transfer steps taking place in the redox process of fentanyl. These 
two peaks became better resolved with higher concentration. Calibration curves were constructed 
from the CV experiments in PBS supplemented with chloride and PBS supplemented with nitrate. 
Figure 10 demonstrates a calibration curve constructed with the supporting electrolyte as PBS with 
chloride ion. Excellent linearity was observed for analysis of fentanyl in both buffers, with 
correlation coefficients above 0.99. Further analysis was focused on improving response to 
fentanyl in order to resolve these peaks and achieve lower detection capability. 
 
 
Figure 10: Cyclic voltammetry of fentanyl at an SPCE in a 5 mL cell containing PBS buffer pH 7.4 (left) 
and resulting calibration curve for CV performed in PBS supplemented with chloride. 
 
 
 A solution of citrate was prepared due to the fentanyl being present with citrate in the 
standard solution. Increasing concentrations of analyte solution were used to assess any 
electroactivity due to citrate using cyclic voltammetry. There was no current response for citrate 



























Peak II y = 0.1298x - 1.1894
R² = 0.9975
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Figure 11: Cyclic voltammetry of citrate in PBS buffer supplemented with chloride and nitrate 
demonstrating no response to citrate and response to only fentanyl. 
 
3.2 Optimization of Parameters and Techniques 
 
Optimization of the pH of the supporting electrolyte demonstrated maximum current 
response at a pH of 8.5 (Figures 12 and 13). Current response peaked at this pH value and 
immediately began to decrease at more basic pH values. Optimization of the pH proved crucial for 
the improvement of the current response to fentanyl. This improvement in detection capability 
may be due to the closeness of the buffer pH with the pKa of fentanyl, which is 8.4.26 This may 
allow for easier electron transfer with the molecule and electrode. 
 
 
Figure 12: Current response to 151 µg/mL fentanyl at differing pH values. Three replicates were performed 

































































Figure 13: Demonstration of peak improvement based on buffer pH showing improved peak current and 
two-peak definition at a pH of 8.5 in PBS. 
 
The optimal pH was tested using PBS buffer supplemented with chloride.  The pH 
measurements were tested in triplicate and demonstrated good reproducibility throughout the 
range, with relative standard deviations of 2.5% for peak I and 5.3% for peak II at a pH of 8.5 
(Table 2).  
 








The optimized pH was used to assess which electrochemical technique would prove most 
useful for analysis. Due to their high sensitivity in detecting low concentrations of analytes, square-
wave voltammetry and differential pulse voltammetry were explored. Through the analysis of a 
single concentration of fentanyl, 151 µg/mL, the parameters for both methods were optimized 





































 % RSD 
pH Peak I Peak II 
5.50 2.6 7.4 
6.00 5.1 9.4 
6.50 2.8 6.8 
7.00 4.4 4.4 
7.40 1.8 2.0 
8.00 2.8 4.8 
8.50 2.5 5.3 
8.97 4.6 4.1 
Average: 3.3 5.5 
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I and II. For SWV, the potential step (Estep), amplitude, and frequency were varied for a scan 
between -0.5 V and 1.6 V. The optimal SWV parameters were determined to be a potential step of 
0.012 V, an amplitude of 0.075 V, and a frequency of 100 Hz. For DPV, the potential pulse, pulse 
time, and scan rate were varied for a scan between the same potential window as for SWV. The 
parameters chosen for DPV were a potential pulse of 0.103 V, a pulse time of 0.01 seconds, and a 
scan rate of 0.6 V/sec. The optimal parameters for each method were chosen and calibration curves 
between 0.336 µg/mL and 16 µg/mL were constructed for each technique. Both methods appeared 
to perform similarly except that the DPV method was unable to see the lowest concentration. Based 
on calibration curves performed for the two methods, SWV resulted in a steeper slope which 
suggested that this method would allow for increased sensitivity, and thus, lower limits of detection 
for fentanyl (Figure 14). As such, SWV was chosen as the electrochemical technique for this 
analysis. 
 
Figure 14: Comparison of calibration curves for SWV (left) and DPV (right) methods demonstrating higher 
sensitivity with SWV. 
 
 A voltammetric stripping approach was also investigated for use in conjunction with SWV 
through the application of varying potentials over a 10-second interval. Calibration curves were 
analyzed for each of the potential changes and the resulting calibration curves were plotted. These 
curves generally demonstrated steeper slopes that SWV or DPV, however, linearity was slightly 
worse although still acceptable with average correlation coefficients greater than 0.98. These 
results demonstrated that the use of stripping voltammetry might hold promise as another method 
for analysis of fentanyl; however, currents were similar to those produced using only SWV.  
y = 2.8153x + 0.7255
R² = 0.9902























y = 1.7239x - 1.0794
R² = 0.9935
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Various buffers were explored for use as the supporting electrolyte. Comparison between 
PBS/Cl and Tris-HCl, both at a pH of 8.5, demonstrated higher current response in the lower 
concentrations of fentanyl when present in the Tris-HCl buffer. For this reason, Tris-HCl was used 
for further analysis, although both buffers proved to be acceptable supporting electrolyte solutions. 
The use of NaOH was also explored; however, as predicted by pH experiments, peaks were either 
absent or extremely poor. Amperometric pre-treatment of the carbon surface in Tris-HCl was 
explored due to observing an effect on the current response from fentanyl. After exploration of 
various potentials and times for pre-treatment, 1.5 V over 40 seconds resulted in the largest current 
response for both peak I and peak II at the lowest concentration. It was expected that this 
improvement in signal resulted from preparing the working electrode surface through the 
application of more positive potential than the oxidation of fentanyl. Finally, an effect in the 
current response was observed during the testing of equilibration time. Increasing the amount of 
time the solution was allowed to stir (for cell measurements) or sit on the electrode surface (for 
drop measurements) before analysis resulted in larger current response. Although increasing the 
amount of time on the electrode surface increased current response, the optimal time was chosen 
to be 320 seconds in order to maintain a fast analysis procedure (Figure 15). This behavior was 
attributed to the adsorption of fentanyl to the carbon working electrode, serving to pre-concentrate 




Figure 15: Stirred equilibration time optimization in a cell containing Tris-HCl at a fentanyl concentration 
of 336 ng/mL. Three replicates per time were tested with an RSD of approximately 9% at 320 seconds (left) 
and stirred equilibration time in 100 µL drop of Tris-HCl at 336 ng/mL with RSD of approximately 4.5 % 
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3.3 Electrochemical detection of fentanyl 
 
The optimized parameters were then used to construct calibration curves for the detection 
of fentanyl. The use of increasing concentrations of fentanyl to a 5 mL electrochemical cell was 
performed for analysis between 75 ng/mL and 6.88 µg/mL. Fentanyl was able to be detected for 
the lowest concentration tested, 75 ng/mL. Figure 5 demonstrates the improved resolution of the 
two oxidation peaks present and shows a small positive potential shift with increasing 
concentration. Peak I appeared at approximately 0.75 V and peak II appeared at approximately 
0.88 V. Construction of calibration curves for peak I and peak II demonstrated two areas of 
linearity, one for concentrations between 75 ng/mL to 637 ng/mL and the second between 1.31 
µg/mL to 6.88 µg/mL. Two regions of linearity have been previously demonstrated within the 
literature for detection of other substance.66–69 This phenomenon is likely due differences in the 
oxidation reaction kinetics as a result of working electrode size, adsorption, and diffusion to the 
surface of the working electrode. Three replicates were performed at each concentration for the 
construction of calibration curves. Linearity was achieved for oxidation peaks I and II within linear 
ranges, as demonstrated in Figure 16.   
 
 
Figure 16: AdS-SWV for the standard addition of fentanyl to a 5 mL electrochemical cell containing 100 
mM Tris-HCl pH 8.5 in triplicate (left) and constructed calibration curve for peaks I and II for fentanyl 
(right).   
 
 
Similar results were obtained for analysis of fentanyl in a 100 microliter drop. 



























y = 2.2819x + 6.065
R² = 0.9909
y = 1.555x + 2.7136
R² = 0.9934
y = 7.1078x + 0.8988
R² = 0.9948
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concentration detected (0.302 µg/mL) using the drop technique was determined to be the limit of 
detection. Also, the drop method demonstrated a slightly noisier response; however, linearity was 
achieved over the concentration range (Figure 8). The correlation coefficients for peak I and peak 
II were 0.9977 and 0.9848, respectively. Three replicates were performed per concentration and 
resulted in an average RSD of approximately 8% for peak I and peak II. The difference in the limit 
of detection can be attributed to solution dynamics within the two methods. When analyzed in a 
cell, the solution can be stirred before analysis. This mechanical action allows for the accumulation 
of the fentanyl via adsorption to the carbon surface and diffusion towards the working electrode. 
However, when the experiment is run as a drop, stirring is not possible, and the electroactivity of 
fentanyl may rely more on diffusion. Although, as explained before, under both the cell and drop 
method, both adsorption and diffusion processes are concurrently observed.  
 
Figure 17: AdS-SWV for increasing concentrations of fentanyl in a 100 µL drop of Tris-HCl on the surface 
of the SPCE (left) and constructed calibration curve for fentanyl assessed in triplicate (right). 
 
 Drop analysis differed from the results generated in a cell due to the presence of only a 
single linear calibration range as opposed to the two observed for the cell method. One explanation 
for this is where the limit of detection lies for the method. Since the LOD was larger when 
performed in a drop, the dynamic range does not extend as low as the one for the cell method. 
Therefore, it is possible that the differing linear range could not be observed, though it may still 
be present. Another explanation could be from the result of the diffusion-limited conditions. Due 
to the absence of stirring the solution, the working electrode surface may not have become 
saturated due to decreased adsorption from lack of fentanyl molecules reaching the surface. 
Therefore, the kinetics between the two methods could be much different. 
y = 3.4258x + 0.6877
R² = 0.9977
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 In order to evaluate the detection methodology chosen herein, the accuracy, precision, and 
limit of detection was determine using the optimized method parameters. This method was 
developed for qualitative identification of fentanyl in samples. As such, the accuracy of the method 
was determined through the analysis of interfering compounds and blank buffer. This information 
can be found in section 4.5 below. However, the method was assessed for use as a quasi-
quantitative method. To this end, samples were analyzed on different electrodes and compared to 
calibration curves obtained before analysis. Analysis of single-blind samples was conducted, 
including negatives, in a 5 mL cell containing Tris-HCl pH 8.5. Negative samples were correctly 
identified as negative, containing no fentanyl, demonstrating a 0% false-positive rate (n=3 for 
blank). Several samples were seen to have significant percent errors; however, these errors were 
in the larger concentrations of fentanyl while the lower concentrations demonstrated good 
accuracy for a presumptive identification technique (Table 3). This discrepancy between low and 
high concentrations could have been due to a single pre-treatment before performing calibration 
curves, demonstrating the increased sensitivity following the pre-treatment, which was lost in the 
calibration curves at higher concentrations, leading to larger currents during unknown analysis, 
consisting of a blank and a single measurement. In order to better observe the trend in accuracy 
for quasi-quantitation, more single-blind samples were prepared and subsequently analyzed by the 
method (Table 4). Again, the same trend was seen demonstrating better accuracy in the low 
concentrations compared to the high concentrations. Another reason for this discrepancy could be 
the effect of fentanyl adsorption on the electrode surface and saturation of the surface at higher 
concentrations. Furthermore, the use of a single electrode for the creation of calibration curves 
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 Table 3: Accuracy of single-blind test samples containing fentanyl (n=2, n=3 for blank) 
* Calculated concentration based on peak I only 
ND = none detected 
 
 
Table 4: Single-blind test sample analysis 
* Calculated concentration based on peak I only 












Error Peak I 
(%) 
RSD Peak I 
(%) 
      
Unknown 1 0.65 0.063 0.080 -22 16 
Unknown 2 15 6.98 3.97 63 22 
Unknown 3 6.2 0.732 0.999 -29 5.1 
Unknown 4 2.6 0.295 0.299 -3.0 7.8 
Unknown 5 ND ND ND ND ND 
Unknown 6 1.4 0.164 0.150 2.4 15 
Unknown 7 20 10.8 5.99 82 4.1 







Error Peak I 
(%)  
      
Unknown 7 ND ND 0.000 NA 
Below LOD Unknown 1 0.81 0.093 0.090 3.4 
Unknown 2 1.03 0.115 0.130 -12 
Unknown 3 1.46 0.158 0.200 -21 
Below  
1 µg/mL 
Unknown 5 2.94 0.309 0.330 -6.3 
Unknown 13 3.87 0.404 0.410 -1.6 
Unknown 6 3.67 0.384 0.500 -23 
Unknown 4 5.10 0.529 0.600 -12 
Unknown 8 5.15 0.732 1.30 -44 
Above 
1 µg/mL 
Unknown 11 6.83 2.34 2.00 17 
Unknown 12 8.70 4.14 3.00 38 
Unknown 9 11.4 6.76 5.00 35 
Unknown 10 10.0 5.35 6.00 -11 




 Reproducibility was assessed through the comparison of calibration curves generated 
through the standard addition method using differing electrodes. The compared calibration curves 
were performed with SPCEs cut from the same sheet and different sheets. The percent relative 
standard deviation was assessed. The average relative standard deviation for calibration curves 
performed in a 5 mL electrochemical cell was approximately 12% for peak I and approximately 
18% for peak II. For the calibration curves performed as a drop on the electrode surface, the 
relative standard deviation was approximately 13% and 15% for peak I and peak II, respectively. 
It was apparent that the current response of peak I from the oxidation of fentanyl provided a more 
reproducible signal across electrodes and different days. Peak II was more variable, which could 
be expected due to the smaller size and absence of the peak for the lower concentrations. 
 
3.4.3 Limit of Detection 
  
 Visual observation of the resulting voltammograms allowed peak I for the oxidation of 
fentanyl to be seen at approximately 75 ng/mL in cell and 300 ng/mL in drop. Three replicate 
calibration curves were performed to lower concentrations in the cell, and an oxidation peak for 
fentanyl was able to be seen at a concentration of approximately 46 ng/mL fentanyl. However, 
statistical analysis of calibration curves was conducted to determine the statistical limit of detection 
above the noise level according to: 
 
1!2 = 3 ×
56
7
          (5) 
 
 where 89  is the standard deviation of the y-intercept and : is the average slope. Based on 
Equation 4, the limit of detection for analysis via the electrochemical cell method was 183 ng/mL 
according to peak I and 108 ng/mL for peak II, resulting in the average LOD of approximately 145 
ng/mL. The same statistical calculations were performed for the drop method and resulted in an 
average LOD of approximately 530 ng/mL. As mentioned previously, these statistical measures of 
the LOD proved to be higher than the visual assessment based on voltammogram peaks. This 
situation is likely attributed to the fact that Equation 5 takes into account the possibility for noise 
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within the system resulting in the multiplication of the leading coefficient. Therefore, it is 
reasonable to utilize these statistical LOD values for the quasi-quantitation limits of the methods.  
 
3.5 Interference Studies 
 
As fentanyl is commonly encountered in mixtures of seized drugs, as well as being used 
with other drugs,60,70 interference studies were conducted in order to determine the ability to detect 
fentanyl in the presence of adulterants. Several possible interfering species were selected due to 
their frequent use as adulterants as described by professionals in the forensic chemistry and 
toxicology field, as well as other drugs identified as being increasingly encountered with fentanyl. 
These substances were the illicit drugs: cocaine and methamphetamine and the adulterants: 
caffeine, quinine, and acetaminophen. These substances were first characterized in the 
electrochemical cell environment with 100 mM Tris-HCl pH 8.5 following the established 
methodology for analysis with adsorptive stripping square-wave voltammetry.  
Methamphetamine was analyzed between 0.149 µg/mL and 33.5 µg/mL. In general, no 
interfering peaks were present at potentials corresponding to fentanyl. However, in higher 
concentrations, the voltammogram shape began to change just after 0.9 V. The development of a 
small and broad peak was observed at approximately 0.92 V. Although there was no defined peak 
at interfering potentials, there was a change in shape resulting in the background current rising at 
earlier potentials. It was possible that this could have affected the ability to detect peak II and 
potentially peak I for fentanyl (Figure 18). 
Caffeine was analyzed between 0.193 µg/mL and 50.1 µg/mL. Larger concentrations of 
caffeine were analyzed due to the absence of any interfering signal at the lower concentrations. 
Regardless of the caffeine concentration, the shape of the voltammogram resulting from 
background current was unchanged and lacked any discernable peak at interfering potentials or 
throughout the potential range. In fact, the voltammograms were of the opposite concavity, 
concave up, further demonstrating the absence of any peaks (Figure 18). 
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Figure 18: Adsorptive stripping square-wave voltammograms for the standard addition of 
methamphetamine (left) and caffeine (right) in a 5 mL electrochemical cell containing 100 mM Tris-HCl 
pH 8.5. 
 
 An investigation into the effect of the change in the shape of the voltammogram at large 
concentrations of methamphetamine was conducted to determine if there would be an influence 
on the ability to detect fentanyl. Various ratios between fentanyl and methamphetamine were 
investigated. At a ratio of 0.3:20 (fentanyl:methamphetamine), fentanyl peak I was readily 
apparent, as was a small peak around 0.9 V. This second peak could be attributed to the mixture 
between methamphetamine and fentanyl, resulting in only peak I being used for the identification 
of fentanyl. At a ratio of 0.3:10, a similar occurrence was noticed; however, peak II appeared to 
be slightly better resolved, although the peak was still small and broad. At a ratio of 1:10, both 
fentanyl oxidation peaks were apparent at their respective potentials, allowing for identification of 



























































Figure 19: Adsorptive stripping square-wave voltammograms in a 5 mL cell with 100 mM Tris-HCl pH 8.5 
for the analysis of fentanyl in the presence of methamphetamine at ratios of 0.3:10 (left), 0.3:20 (middle), 
and 1:10 (right), respectively. 
 
Cocaine was analyzed between 0.303 µg/mL and 13.4 µg/mL. The presence of an 
interfering peak was immediately observed. The interfering cocaine oxidation peak was 
determined to be present between 0.88 V and 0.9 V, the location of peak II for fentanyl. However, 
only a single peak was present with good resolution and peak shape, which could allow for the 
observation of peak I for fentanyl. Decent linearity was achieved for the concentration range tested 
with a coefficient of determination of 0.9784 (Figure 20). 
 
 
Figure 20: Adsorptive stripping square-wave voltammograms for the standard addition of cocaine in a 5 
mL electrochemical cell containing 100 mM Tris-HCl pH 8.5 and the corresponding standard curve. 
 
 In order to determine the effect of this cocaine peak, varying ratios of fentanyl to cocaine 
were analyzed. At 0.3:10 µg/mL, the cocaine oxidation peak overshadowed peak I for fentanyl. 
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µg/mL, the presence of fentanyl peak I at 0.75 V became readily apparent as a shoulder (Figure 
21). Finally, at a ratio of 1:3 µg/mL, the peak shape began to resemble that of just fentanyl with 
the exception of the largest peak being peak II. The fentanyl peak at 0.75 V became resolved from 
the overlapping peaks of cocaine and fentanyl peak II (Figure 21). Therefore, it was determined 
that peak I could be used for the identification of fentanyl when present in mixtures and that it 
could be possible to determine mixtures based on the ratio of peak height between peaks 
corresponding to the potentials of peak I and peak II for fentanyl. These results also suggest the 
possibility of performing a semi-quantitative analysis for the approximate concentration ratio 
between fentanyl and interfering compounds. 
 
 
Figure 21: Adsorptive stripping square-wave voltammograms in a 5 mL cell with 100 mM Tris-HCl pH 8.5 
for the analysis of fentanyl in the presence of cocaine at ratios of 0.3:10 (left), 1:10 (middle), and 1:3 
(right), respectively. 
  
 Quinine was analyzed at concentrations between 0.099 µg/mL and 9.0 µg/mL. Quinine 
was sparingly soluble in the aqueous Tris-HCl buffer, which was confirmed by the literature. Due 
to this insolubility, it could be possible that quinine may not be present as high concentrations in 
oral fluid or could be removed as an interfering adulterant during the analysis of powder samples 
when placed in the aqueous buffer. Regardless, an investigation into quinine was undertaken. After 
achieving solubility within the solution, increasing concentrations of quinine into the cell resulted 
in an oxidation peak present at 0.9 V. Similar to cocaine; this peak would interfere with the 
detection of peak II for fentanyl. When compared with cocaine, the resolution of the quinine peak 
was better, particularly the resolution on the more positive potential side. This was an indication 
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Construction of the resulting calibration curve demonstrated two regions of linearity, of which, the 
lower concentration region had a slope that was approximately eight times greater than the slope 
obtained for cocaine (Figure 22). 
 
 
Figure 22: Adsorptive stripping square-wave voltammograms for the standard addition of quinine in a 5 
mL electrochemical cell containing 100 mM Tris-HCl pH 8.5 and corresponding calibration curve. 
 
 The effect of quinine on the detection capability of the method for fentanyl was tested in 
the same way as cocaine. The following ratios were analyzed between fentanyl and quinine: 0.3:10, 
1:10, and 1:3. Unlike cocaine, no indication of fentanyl was seen at the 0.3 µg/mL fentanyl with 
10 µg/mL quinine. The quinine peak was able to overshadow any electroactivity of the fentanyl 
within the cell. At a ratio of 1:10, peak I for fentanyl was observed as a small shoulder against the 
strong peak for quinine. Lastly, at a ratio of 1:3, fentanyl peak I was readily apparent at 
approximately 0.75 V, resulting in the inversed peak ratio that was seen with cocaine and fentanyl 
(Figure 23). This ratio further provided evidence that peak I could be used for identification 
purposes while peaks present at the potential of fentanyl peak II could be useful indicators of the 
presence of interfering compounds. Similarly, should peak II be present as a smaller peak than 
peak I, it could indicate the presence of a pure fentanyl sample or a sample without interference 
and could serve as a secondary means of identification, providing stronger evidence for the 





















































y = 8.8331x + 4.5231
R² = 0.9656
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Figure 23: Adsorptive stripping square-wave voltammograms in a 5 mL cell with 100 mM Tris-HCl pH 8.5 
for the analysis of fentanyl in the presence of quinine at ratios of 0.3:10 (left), 1:10 (middle), and 1:3 (right), 
respectively. 
 
Acetaminophen is a commonly encountered medicine for the treatment of inflammation 
and mild pain. Due to the general use of the compound, it is reasonable to expect that it may be 
naturally present in collected oral fluid samples or other biological samples. Furthermore, it is 
commonly used as an adulterant. Therefore, acetaminophen was analyzed between 0.151 µg/mL 
and 13.8 µg/mL. After analysis of increasing concentrations of acetaminophen, it was observed 
that there was no interference at potentials corresponding to the oxidation of fentanyl. However, 
acetaminophen did demonstrate electroactivity through the presence of an oxidation peak 
generated at a potential of approximately 0.28 V. Analysis of the calibration curve constructed 
demonstrated excellent sensitivity with a coefficient of determination of 0.9988 (Figure 24). 
 
 
Figure 24: Adsorptive stripping square-wave voltammograms for the standard addition of acetaminophen 
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The electroactivity of acetaminophen, in this case, was considered to be fortuitous due to 
the potential of oxidation being centered at 0.28 V. This potential was shown to not interfere with 
the signal for fentanyl while also allowing acetaminophen to be detected simultaneously (Figure 
25). This behavior would prove to be a useful application when analyzing samples that may contain 
both compounds because, in addition to the identification of fentanyl, acetaminophen can also be 
identified in the sample, and possibly quantified. It was demonstrated that large concentrations of 
acetaminophen did not affect the ability of the method to detect both fentanyl oxidation peaks. 
 
 
Figure 25: Adsorptive stripping square-wave voltammograms in a 5 mL cell with 100 mM Tris-HCl pH 8.5 
for the analysis of fentanyl in the presence of acetaminophen at ratios of 0.3:10 (left), 1:10 (middle), and 
1:3 (right), respectively. 
 
 
3.6 Hypothesized Redox Mechanism 
 
 In 2003, Garrido et al. reported the electrooxidation of heroin at a glassy carbon electrode 
with a glassy carbon rod auxiliary electrode and Ag/AgCl reference electrode. The authors 
observed the occurrence of two peaks at basic pH, as demonstrated in this work.20 The authors 
attributed these two peaks to the oxidation of the tertiary amine and the oxidation of the newly 
formed secondary amine. The authors reported that the peak present at less positive potential 
resulted from the oxidation of the tertiary amine and the peak at more positive potential was from 
the oxidation of the newly formed product, a secondary amine.20 Garrido et al. confirmed this 
through their electrochemical analysis of norheroin. This oxidation mechanism would also be 
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oxidized before the secondary amine. Furthermore, the larger peak could be expected to be 
attributed to the substance in higher concentration within the system.  
 The above-mentioned oxidation pathway has been supported in the literature. In a paper 
detailing the oxidation of amines, Masui et al. state the observance of two oxidation peaks for 
tertiary amines, a single peak for secondary amines, and the absence of oxidation peaks for primary 
amines.71 Furthermore, the authors provide evidence for the findings of this work and the 
previously mentioned work stating that amines are more easily oxidized within a basic solution, 
that there exists a linear relationship between the pKa of the compound and the peak potential (Ep), 
and that oxidation of tertiary amines occurs at lower Ep than the oxidation peak of secondary 
amines.71,72 The authors suggested a 2-electron oxidation process for triethylamine involving an 
aminium cation and reaction with water to form a secondary amine and aldehyde.71  
 However, these two proposed mechanisms partially disagree with Smith et al. who describe 
the oxidation process of substituted tertiary amines in basic solution with glassy carbon.73 Rather 
than describing the oxidation of a tertiary amine followed by the secondary amine, the authors 
proposed that both peaks were due to the same process, namely the oxidation of the tertiary amine. 
This phenomenon occurs due to the oxidation (at a less anodic potential) of the species adsorbed 
to the electrode surface and the oxidation of the analyte (at more anodic potential) due to diffusion 
to the electrode.73 The authors further demonstrate the analyte adsorption to the electrode through 
the lone pairs on the nitrogen atoms.73 
 Consideration of the papers mentioned above detailing possible mechanisms for the 
oxidation of amines, oxidation of cinnarizine by Hegde et al., 74 and work demonstrating fentanyl 
oxidation by Goodchild et al.,33 as well as this work, may aid in the elucidation of the oxidation 
mechanism of fentanyl. It was shown that norfentanyl did not present any oxidation peak while 4-
ANPP demonstrated two oxidative peaks with better peak resolution than fentanyl, confirming the 
location of the tertiary amine oxidation.33 We propose that peak I, seen in our work, for the 
oxidation of fentanyl cannot be due to oxidation of the tertiary amine present as the amide group 
in fentanyl as this process more likely occurs through hydrolysis in acidic conditions compared 
with the buffer pH of 8.5 used herein. Furthermore, we do not support the mechanism explained 
through the oxidation of the tertiary amine for peak I followed by the oxidation of the product 
secondary amine for peak II. Oxidation of the tertiary amine as N-dealkylation on fentanyl would 
result in norfentanyl. However, the suggestion of peak II arising from the oxidation of the 
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secondary amine of norfentanyl is not supported in the literature, as Goodchild et al. demonstrated 
a complete lack of an oxidation peak.33 Therefore, both peaks must be due to the N-dealkylation 
of fentanyl to norfentanyl. As this work demonstrated, peak current increased as the amount of 
time stirred increased, suggesting that an adsorption process was occurring within the system. In 
addition, with much longer times, the difference in peak current decreased, further suggesting an 
adsorption process through the observable saturation of the electrode surface based on peak current 
versus time stirred. As such, it is proposed that the oxidative mechanism of fentanyl, resulting in 
peak I and peak II in this work, is due only to the oxidation of the tertiary amine through N-
dealkylation. The presence of the two peaks can be explained through the oxidation processes of 
adsorbed species and species diffusing to the electrode surface. Cyclic voltammetry was utilized 
as a means to further support this claim. CV of fentanyl was analyzed under varying scan rates 
between 0.1 V/s and 0.75 V/s. Plots of peak current versus the scan rate (adsorption) and the square 
root of the scan rate (diffusion) were analyzed. Linearity was observed in both plots suggesting 
that both processes were occurring (Figure 26).  
 
Figure 26: Cyclic voltammograms collected at varying scan rates (right) to demonstrate that the electro-
oxidation of fentanyl involves both diffusion (top left) and adsorption (bottom left). 
 
Further support of both an adsorption and diffusion process is the presence of an oxidation 
peak in the analysis of 4-ANPP that demonstrates improved peak resolution for peak I and peak 
II.33 We suspect that this is due to a higher affinity of 4-ANPP for the electrode surface due to 
decreased steric hindrance and greater access to the lone pair as a result of the absence of the amide 
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group. Lastly, this process was determined to be an irreversible electron transfer for fentanyl, 
which was supported through analysis of fentanyl in a drop by successive scans via cyclic 
voltammetry showing the decrease in peak current and shape with each successive scan (Figure 
27). This experiment demonstrated the irreversible nature of the oxidation due to the lack of a 
reduction peak and the decreasing oxidation current, suggesting that the species is being used up 
rather than recycled in the process. The proposed electrooxidation mechanism of fentanyl can be 
seen in Figure 28 as well as the previously proposed mechanism. 
 
 
Figure 27: Successive cyclic voltammograms on a 100 µL drop of 1 mM fentanyl in Tris-HCl pH 8.5, 






























Figure 28: Proposed mechanism for the electro-oxidation of fentanyl and the previously suggested 
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 In order to provide further evidence about the electro-oxidation process occurring, samples 
of fentanyl analyzed as a drop on the surface were tested using the AdS-SWV procedure. However, 
drops were analyzed over a varying number of AdS-SWV scans (0, 10, 20, 40, and 80 scans). 
These drops were then transferred to vials and analyzed using the developed LC/MS/MS method 
detailed in Part III of this thesis. Analysis of these samples demonstrated the presence of fentanyl 
and some 4-ANPP, but more importantly, the lack of norfentanyl in the 0-scan (fentanyl stock) 
sample. Upon an increasing number of scans, the amount of norfentanyl can be seen to increase, 
demonstrating the electro-oxidation of fentanyl to norfentanyl (Figure 29). 
 
 
Figure 29: LC/MS/MS results following the electrochemical analysis of fentanyl demonstrating the 
increasing concentration of norfentanyl, supporting the proposed oxidation pathway. 
 
3.7 Nanomaterial Modifications 
 
 Various types of nanomodifications were explored using screen-printed carbon electrodes 
to determine whether another type of surface could improve the sensitivity or linearity of the 
detection of fentanyl.  
 Rhodium nanoparticles were deposited on the working electrode surface (SPCRhnpsE) 
through the application of -0.25 V for 480 seconds. When utilizing the adsorptive stripping 
approach for 320 seconds with the optimized square-wave procedure, calibration curves were 
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electrode surface was performed before deposition of the Rhodium onto the surface. Rhodium 
experiments demonstrated promise in their ability to detect fentanyl and exhibited two regions of 
linearity. An example calibration curve and voltammograms are shown in Figure 30. Only a single 
peak, corresponding to the potential of peak I, was observed for the majority of the concentrations. 
At higher concentrations, the second peak became apparent, but only peak I was assessed in the 
calibration curve.  
 
 
Figure 30: AdS-SWV for increasing concentrations of fentanyl in Tris-HCl at a modified SPCRhnpsE (left) 
and constructed calibration curve for fentanyl (right). 
 
 Multiwalled carbon nanotubes were explored as modifications to the working electrode 
surface (SPCMWCNTE). Surface exploration occurred before the use of the 320 second equilibration 
time. Therefore, these experiments were carried out using the optimized SWV technique along 
with a 20 second equilibration time. Linearity was achieved using MWCNTs; however, only a 
single peak was able to be seen in the potential range corresponding to fentanyl (Figure 31). 
Furthermore, the method was unable to detect the lowest concentration tested, which was 336 
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Part II: Electrochemical Analysis of Fentanyl 
 58 
 
Figure 31: SWV for increasing concentrations of fentanyl in Tris-HCl at a modified SPCMWCNTE (left) and 
constructed calibration curve for fentanyl (right). 
 
The use of graphene oxide was investigated next. Following the reduction of the graphene 
oxide, the surface was analyzed similarly to the MWCNTs. Two replicates using SPCrGOEs were 
assessed. Extremely poor linearity was observed for this approach and demonstrated a ‘U’ shape 
in the constructed calibration curve from two replicate experiments. The resulting voltammograms 
and calibration curve can be seen in Figure 32. A high background current could be seen that 
diminished with each new concentration, owing to the seemingly flipped voltammograms with the 
highest concentration below lower concentrations. At higher concentrations of fentanyl, the 































































Figure 32: SWV for increasing concentrations of fentanyl in Tris-HCl at a modified SPCrGOE (left) and 
constructed calibration curve for fentanyl (right). 
 
 Gold and silver nanoparticles were explored due to their simplicity of formation on the 
electrode surface and inherent ability to boost the signal. Silver solutions of 0.1 mM and 5 mM 
were investigated with a deposition time of 10 seconds. Similar linearity was achieved for both 
conditions; however, the replicate performed from the deposition of the 0.1 mM silver solution 
demonstrated higher slopes in the calibration curve, suggesting greater sensitivity. Figure 33 shows 
the resulting adsorptive stripping square-wave voltammograms for analysis of fentanyl. Both peak 
I and peak II can be seen at their corresponding potentials, as well as a large peak around 0 V. This 
peak was seen to diminish with each successive concentration run and can be attributed to the 
interaction of silver and chloride within the system.  
 Gold nanoparticles also allowed for the detection of fentanyl. However, only a single peak 
was present rather than both peaks. Also, a large oxidation peak was observed at approximately 1 
V. This can be attributed to the oxidation related to the presence of the gold nanoparticles on the 
surface of the electrode. This peak, due to the presence of gold, was seen in previous experiments 
involving the use of gold nanoparticles. It was determined that the use of gold nanoparticles might 
not provide an acceptable detection platform for fentanyl due to the fentanyl peaks appearing 

























































Figure 33: SWV for increasing concentrations of fentanyl in Tris-HCl at a modified SPCAgnpsE (left) and 
constructed calibration curve for fentanyl (right). 
 
 
 The combination of silver nanoparticles with MWCNTs was explored. For each electrode, 
a silver solution of 0.1 mM was used for the deposition of the nanoparticles for 10 seconds. 
MWCNT solutions were made to 0.015, 0.075, 0.15, 0.3, 3 mg/mL and added to the electrode 
surface. The electrode response was assessed based on peak current height and on peak shape for 
both peak I and peak II for fentanyl. The Agnps/MWCNT (3 mg/mL) electrode produced the highest 
current response for the concentrations tested. However, peak II was lost in the lowest 
concentration, and a noisier signal was observed. The second-best modification was with the 
MWCNT concentration of 0.075 mg/mL. Both peaks were seen with higher peak currents than the 
other electrodes. Peak shape was also improved from the remaining electrodes. This approach 
could prove a useful detection strategy; however, sensitivity would need to be improved since the 
lowest concentration tested was 671 ng/mL. Figure 34 demonstrates the voltammograms and 
calibration curve obtained for the electrode modified with Agnps and 0.075 mg/mL MWCNTs. The 
linearity achieved using this modification technique was not as desirable; however, other 
concentrations and replicates would be needed to assess the variability and to determine if two 
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Figure 34: SWV for increasing concentrations of fentanyl in Tris-HCl at a modified SPCAgnps/MWCNTE (left) 
and constructed calibration curve for fentanyl (right). 
 
 Other possible modifications and detection methods were attempted including the use of 
SPCEs with carbon paths, unmodified and with silver nanoparticles; a glassy carbon conventional 
electrode; and a conventional silver electrode. These methods demonstrated poor linearity and 
were not investigated further. However, the use of the conventional silver and glassy carbon 
electrodes could represent a possibility for testing, as lower concentrations were not examined to 
determine two regions of linearity. Nonetheless, the use of conventional electrodes would pose a 
problem for work performed in the field. A comparison of the tested modifications, including the 
final method on bare carbon can be found in Table 5. 
 
3.8 Anodic Stripping Square-Wave Voltammetry 
 
 Rather than utilizing the anodic pre-treatment and 320 second equilibration time, the use 
of an anodic stripping method was investigated for use prior to the application of the square-wave 
method for the detection of fentanyl. This approach was explored due to the proposed adsorption 
mechanism, which could improve detection capabilities through amperometric adsorption of 
fentanyl before oxidation. Anodic stripping conditions were assessed previously, and a potential 
of 0.1 V was determined to be optimal based on peak potential, slope, and correlation coefficient. 
No significant difference was seen between 60 seconds versus 120 seconds versus 520 seconds. 
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of the peaks. However, the performance was comparable to the pre-treatment method and was not 
further explored. 
 
























Modification Technique Lowest Concentration Detected (µg/mL) 
Linear Range 
(µg/mL) R
2 Current in 1 µg/mL 
Concentration (µA) 
      
Pre-treatment AdS-SWV 0.076 
0.075 to 0.64 
1.3 to 6.9 
0.9948 
0.9909 
4.9 (0.64 µg/mL)     
8.54 (1.3 µg/mL) 
Rh nps AdS-SWV 0.076 
0.075 to 0.64 
1.3 to 6.6 
0.9933 
0.9989 8.62 (0.64 µg/mL) 
MWCNTs SWV 1.01 1.01 to 16 0.9883 0.290 
rGO SWV 0.336 NA Not Linear -- 
Ag nps SWV 0.336 0.336 to 6.6 0.9506 5.90 
Ag/MWCNTs SWV 0.336 0.336 to 6.6 0.9370 3.33 
Au nps  SWV 0.336 0.336 to 6.6 0.9977 1.96 
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The electroactivity of fentanyl at a screen-printed carbon electrode was demonstrated 
through the use of adsorptive stripping square-wave voltammetry. The electro-oxidation was 
observed to take place through two separate electron transfer events, giving rise to two oxidation 
peaks. The first peak, referred to as peak I, was present at a potential of approximately 0.75 V. The 
second peak, referred to as peak II, was present at approximately 0.88 V. The oxidative behavior 
of fentanyl was attributed to the presence of the amine groups within the molecule. The electro-
oxidative mechanism for fentanyl is hypothesized to be a result of oxidation of the tertiary amine 
present in the piperidine ring, resulting in dealkylation to form norfentanyl.  
The presence of peak I was attributed to the oxidation of adsorbed fentanyl species, while 
peak II was attributed to the oxidation of diffuse fentanyl species. The demonstrated detection 
method was shown to provide good reproducibility and limits of detection for analysis within an 
electrochemical cell and analysis within a drop on the electrode surface. The limit of detection for 
analysis within a cell was calculated to be approximately 145 ng/mL fentanyl, and the limit of 
detection within a drop was calculated to be about 530 ng/mL. However, fentanyl was able to be 
detected below these calculated values, as evidenced by the presence of oxidation peaks as low as 
76 ng/mL for cell and approximately 300 ng/mL for drop analysis. A peak could be observed for 
analysis in a cell at 46 ng/mL fentanyl. The reproducibility of the method, expressed as RSD, in 
the cell, and in the drop, was 12% and 13% for peak I and 18% and 15% for peak II, respectively. 
The use of unmodified SPCEs allowed this detection method to be simple, cheap, reproducible, 
and did not suffer from electrode degradation due to storage time or conditions. Although the 
electrode surface was unmodified, it was shown that there was minimal interference from 
commonly encountered drugs and adulterants found with fentanyl. Methamphetamine, caffeine, 
and acetaminophen did not interfere with the detection of fentanyl, allowing peak I and peak II to 
be observed at various ratios, providing identification. Analysis of cocaine and quinine resulted in 
oxidation peaks overlapping with peak II of fentanyl. At dilute concentration ratios, the oxidation 
of fentanyl was not able to be detected when present with quinine and, to a lesser extent, cocaine. 
However, with less dilute concentration ratios, peak I of fentanyl was observed, allowing for the 
identification of fentanyl within the sample and generation of the identification criteria, the 
presence of a peak at approximately 0.75 V. The presence of the second peak along with the ratio 
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between peak I and peak II may allow for further information to be discovered about the sample 
such as the presence of a mixture versus a pure sample.   
 The oxidative mechanism was proposed based on the literature available for the oxidation 
of amines, as well as, voltammetric data present for fentanyl and related compounds. The proposed 
mechanism rejects some previously hypothesized oxidation mechanisms of tertiary amines where 
the presence of two peaks was observed. Where others have suggested the two-step oxidation 
process of the tertiary amine followed by the oxidation of the newly formed secondary amine 
product, we agree with literature supporting the effect of adsorption of the tertiary diamine to the 
electrode surface and present the mechanism whereby the observed peaks are a result of oxidation 
of species diffusing to the surface and of species adsorbed to the surface, shifting the potential. 
 Several other detection surfaces were investigated and were shown to have promise in 
future work. The use of rhodium, gold, and silver nanoparticles, as well as MWCNTs, was 
demonstrated to achieve response to fentanyl with acceptable linearity. However, the gold and 
silver surfaces and MWCNTs did not demonstrate the same sensitivity as seen with rhodium or 
the AdS-SWV SPCE method, although the fully optimized method was not explored. 
 The combined use of anodic stripping with SWV was investigated and shown to 
demonstrate good linearity and peak shape, however, there was not a noticeable advantage to using 
this process over the pre-treatment process, as evidenced by the calibration curves obtained.  
 
4.2 Future Work 
 
 Future work related to this project will be focused on the improvements of the 
electrochemical sensor for fentanyl. Modifications to the electrode surface will be explored in 
more depth in order to extend the limits of detection lower and achieve better reproducibility. To 
this end, the electrochemical technique will be further investigated and optimized to determine a 
method that is suitable for the analysis of multiple analytes in such a way that selectivity can be 
achieved with low detection limits. More work will be conducted to improve the quasi-quantitative 
nature of the identification of the target analytes to provide better quantitative data. Fentanyl 
analogs may be explored to determine the selectivity of the technique and other techniques for 
differentiating between the fentanyl analogs. Furthermore, the electro-oxidative mechanism of 
fentanyl may be investigated through the analysis of similar compounds, metabolites, degradation 
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products, and precursors to elucidate the oxidative mechanism further. The analysis of these 
compounds will provide information regarding the oxidative behavior resulting in peak I and peak 
II seen in this work. Investigations into the reasons behind the two regions of linearity will also be 
undertaken to explain this observed phenomenon.  
Expansion of the capabilities of simultaneous multi-analyte analysis will be explored to 
provide a means of presumptive identification of unknown substances in the field. Future work 
may also focus on the oral fluid matrix. To this end, methods will be developed to allow for the 
electrochemical detection of target analytes in oral fluid both in the laboratory and in the field. 
Field analysis will require minimal sample preparation and ease of testing. These investigations 
will be targeted toward improving the capabilities of electrochemical detection methodologies for 
use in forensic science to provide more data toward the future incorporation of electrochemistry 
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1.1. Oral Fluid 
 
 The combined secretions from the serous-cells and mucous-cells of the parotid, sublingual, 
and submandibular salivary glands in the human mouth contribute to the make-up of oral fluid.75 
These glands secrete approximately 25%, 4%, and 71% of the liquid termed oral fluid, 
respectively.40,75 Between 800-1000 other minor glands contribute to this mixture. The 
composition of the oral fluid is: 98% water, 0.7% proteins (amylases), and 0.26% glycoproteins 
(mucins) and electrolytes. These values are attributed to the different types of cells, and generally, 
results in a slightly acidic environment, although the pH of oral fluid can range between 5.5 to 
7.9.75 The serous cells produce an aqueous solution that is high in electrolytes and is colorless, 
while the mucosal contribution contains a viscous mixture of proteins, polysaccharides, and 
glycoproteins. Approximately 500-1500 mL of oral fluid is produced at an average rate of 0.6 
mL/min for a single day.75  
 The use of oral fluid as a matrix for analysis dates back to the mid-19th century and early 
1900s but was first proposed for detecting drugs in forensic settings in the 1970s.75 This has 
progressed to be targeted toward driving under the influence (DUI) cases for on-site testing since 
oral fluid collection is considered non-invasive.40,75  
The “metabolic profile” of drugs in oral fluid differs from that of blood and urine. The 
detection window in this matrix is several hours up to two days or more for some analytes.75 Oral 
fluid has the advantage of being able to collect a sample that is non-invasive without the problems 
associated with gender concerns, accessibility, and adulteration.40,75 Furthermore, the presence of 
drugs within blood and plasma should be accessible within the saliva since oral fluid can be thought 
of as a filtrate of blood and is derived from plasma.40,75 The major advantage of an oral fluid matrix 
is that the parent drugs are often present in higher concentration versus their metabolites when 
compared to blood. However, comparisons between oral fluid concentrations and the levels of the 
drug in the blood are rarely reliable.75 Finally, the low protein content means that there should be 
less binding of drugs than in plasma.40 
Multiple challenges are also encountered with an oral fluid matrix. One of those 
disadvantages is the detection window for drugs, but this is also an advantage because oral fluid 
can then be used to assess recent drug use.75 Other disadvantages are changes in pH (pH 7.4 for 
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stimulated saliva),40 low analyte levels, and contamination from drugs administered orally or 
through intranasal administration.75  
Drugs enter the oral fluid through three mechanisms: passive diffusion, ultrafiltration, and 
active secretion from blood. These mechanisms are affected by the molecular weight of the 
compound, degree of ionization in oral fluid pH, and lipid solubility.75 Ionized, protein-bound, and 
molecules greater than 500 Da are generally hindered. Typically, basic and ionized drugs are more 
easily partitioned from the blood to the oral fluid and have oral fluid-blood partition (OF/P) ratios 
greater than 1.75 Common opioids such as codeine, methadone, and morphine have OF/Ps of 8.8, 
2.9, and 9.8, respectively. This suggests that the concentrations of these drugs can be found higher 
in oral fluid than in blood. Additionally, an approximate 100-fold increase in the partition ratio 
can be seen when the drug is snorted or smoked.75 Being a basic compound with a pKa of 8.4, 
fentanyl will be expected to have an OF/P ratio greater than 1 since it will remain in the ionized 
state at physiological pH and may be transported into the oral fluid with the aid of p-glycoprotein.76 
In chronic pain patients, the average oral fluid concentration was found to be 4.5 ± 2.6 ng/mL for 
fentanyl and 1.5 ± 0.8 ng/mL for norfentanyl.77 Another study from 11 cancer patients with a 
transdermal patch had an average oral fluid concentration of 3.334 ng/mL for fentanyl and 0.517 
ng/mL for norfentanyl compared with 0.785 ng/mL and 0.531 ng/mL in plasma, respectively.27 
Oral fluid collection generally consists of spitting into vials or using an absorbent material. 
In order to stabilize the samples, appropriate buffers must be used to house the oral fluid samples.75 
The Driving Under the Influence of Drugs (DRUID) project in Europe examined the usefulness of 
oral fluid along with blood samples. This program determined general equivalent cut-off values 
for 23 substances in oral fluid including codeine (94 ng/mL), methadone (22 ng/mL), morphine 
(95 ng/mL), and 6-MAM (16 ng/mL).75 However, collection performed via stimulation comes with 
challenges for some drugs and can result in lower drug concentrations than unstimulated saliva.40  
A major advantage of using oral fluid as a matrix is that the analysis can proceed 
immediately without additional sample preparation steps. A simple dilute-and-shoot approach 
(oral fluid diluted in buffer), could be used alone or in combination with other sample preparation 
schemes involving, for example, solid-phase extraction or liquid-liquid extraction.75 A crucial 
aspect to consider is the presence of mucoproteins, which can bind some drugs and interfere with 
the overall analysis. Interferences by mucin can be alleviated using a cycle of freeze-thaw. 
Currently, many forensic laboratories use immunoassays as a presumptive, fast drug-class 
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identification method followed by different mass spectrometric platforms for confirmatory 
methods employing either GC-MS, GC-MS/MS, LC-MS, or LC-MS/MS.75 
 
1.2. Method Validation: LC/MS 
 
 Method validation is a critical aspect of analytical protocols in order to ensure the 
reliability and reproducibility of the analyses conducted. Several organizations have written and 
issued documents detailing their recommendations on how to conduct validation studies and 
what parameters are essential to consider for various types of analyses.78 Validation, as provided 
by ISO 17025, is the “confirmation by examination and provision of objective evidence that the 
particular requirements for a specific intended use are fulfilled.” 79 Commonly, the term “fit for 
purpose”79 is used when discussing method validation or methods in general. Although this 
term can be vague or arbitrary, Eurachem, the American Academy of Forensic Science 
Standards Board (ASB), and other entities have attempted to outline parameters that they deem 
critical to the assessment of the “success” of methods. 
 
1.2.1. Quality of Results 
 
 The quality of a result can be expressed using various performance measures. Typically, 
these include bias and precision.79 Bias refers to the assessment of the trueness of a 
measurement. As trueness cannot be measured since it is based on an infinite number of 
measurements, bias becomes the approximation of this concept and is the difference between 
the mean value of the results and the known value, expressed as percent bias.79 ASB 
recommends that bias be assessed in triplicate at low, medium, and high concentrations over 
five different runs using a pooled fortified matrix with a maximum acceptable bias of ±20%.65  
 Precision provides a measure of how repeatable the method’s results are79 and is 





(100)              (6) 
 
 where s is the standard deviation of the results and E̅ is the mean of the results.65 Of 
interest to LC/MS methods are two types of precision that should be assessed: within-run 
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precision and between-run precision. It is recommended that these studies be carried out in the 
same way as the bias studies with a maximum acceptable %CV of ±20%.  
 
1.2.2. Calibration Model and Carryover 
 
 For quantitative procedures, a working range of concentrations is generally determined 
for analysis. In order to analyze and evaluate samples within this range, it must be shown that 
the analytical response has a relationship with the analyte concentration.65 In general, linear 
models are used most often, and both the correlation coefficient and residual plots65,78 should 
be used when assessing a model. It should be noted that methods spanning more than one order 
of magnitude will generally demonstrate heteroscedasticity and be considered candidates for 
weighted models.78 The assessment should be performed on the combined data from 5 replicates 
of at least six different non-zero calibrators.65 Carryover must also be assessed for methods due 
to the possible contamination of subsequent samples during the analysis process. The procedure 
for addressing carryover is to analyze a blank sample following high concentrations. It is 
recommended that carryover be assessed in triplicate for all analytes.65 
 
1.2.3. Interference/Selectivity Studies 
 
LC/MS methods need to be highly selective for the chosen analytes in the presence of 
interfering compounds. Interference can affect the method response through signal 
enhancement or suppression of the signal, and in turn, affect quantitation.79 Analysis of 
interferences can be accomplished in several ways. The first is to demonstrate that there are no 
interferences from the chosen matrix through the analysis of at least ten different matrix 
sources.65 Commonly encountered substances that may be expected to be present in authentic 
samples must also be analyzed to determine that they will not interfere with the analysis.78 This 
can be accomplished by analyzing authentic samples or analyzing the compounds using the 
method.65 Lastly, when utilizing isotopically labeled internal standards, it should be 
demonstrated that the internal standards are free from non-labeled compounds by analyzing the 
internal standards through the monitoring of the analyte transitions.65 
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1.2.4 Recovery, Matrix Effects, and Process Efficiency 
 
 Recovery (RE) refers to the ability to obtain the analyte after it has undergone sample 
processing such as solid-phase or liquid-liquid extraction. Although ASB standard 036 does not 
specifically address recovery, some journals require that recovery be assessed78 and is 
commonplace in method development for LC/MS. Matrix effects (ME), also referred to as 
ionization suppression or enhancement, is a familiar yet not fully understood phenomenon.78,80 
Considering LC/MS, matrix effects can be the result of substances that may co-elute with analytes 
of interest, whether they are also detected or not.80 The presence of these components during the 
ionization process can inhibit or enhance the ionization of the parent molecule, resulting in 
increased or decreased signal.80 Process efficiency (PE) refers to the overall ability of the method 
to achieve the desired results and is also not specifically addressed in ASB Standard 036 or 
Eurachem. Matuszewski et al. describe a protocol for the assessment of recovery, matrix effects, 
and process efficiency.80 The procedure describes the preparation of 3 different sets of samples. 
The first set (A) consisted of neat samples, the second set (B) consisted of processed samples 
spiked after extraction, and the third set (C) consisted of processed samples spiked before 















× 100      (9) 
 
 where the values of RE, ME, and PE are considered “perfect” at 100%.80 However, ASB 
standard 036 suggests that the calculation of matrix effect be determined from 0%, where positive 
values refer to ionization enhancement and negative values refer to ionization suppression by 
subtracting the resulting fraction from 1.65 These validation parameters should be assessed at both 
low and high concentrations using at least 10 sources of matrix, if possible, with matrix effects not 
exceeding ± 25%.65 
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1.2.5 Limit of Detection and Lowest Limit of Quantitation 
 
 The limit of detection (LOD) refers to the lowest concentration where the target analyte 
can be reliably identified but does not fulfill the requirements for quantification.78 This differs 
from the lowest limit of quantification, which is the lowest concentration of the analyte that can 
be reliably quantified.78 A number of methods have been outlined in the literature for the 
determination of the limit of detection. These include using the lowest non-zero calibrator, 
estimation through the use of reference materials, and estimation using a linear calibration curve. 






      (10) 
 
where sy is the standard deviation of the y-intercept of at least three calibration curves and Avgm 
is the average slope of the three curves.65 The LLOQ can also be assessed using several methods.65 
However, it is common to report the LLOQ as the lowest non-zero calibrator as it is generally 
considered inappropriate to perform quantitation outside of the established calibration curve. A 
rule-of-thumb for assessing the LLOQ includes determining if the signal-to-noise ratio is greater 




 Many reasons require the stability of samples to be assessed, including storage for 
subsequent or later analysis such as in forensic science, instrument malfunctions or errors, and 
storage or holding of processed samples. Therefore, it is necessary to ensure that target analytes 
will still be detected under the abovementioned conditions. Several reports and guidelines 
recommend the assessment of processed sample stability in the freezer, refrigerator, or 
autosampler and assessment of freeze/thaw stability.78 It is recommended that stability be 
measured at low and high concentrations of fortified matrix measured in triplicate. Analysis of 
samples is performed by comparing the peak area or the peak area ratio of time zero samples to 
each subsequent stability run.65 Time intervals can be chosen to span set times or times commonly 
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2’-fluoro ortho-fluorofentanyl, 4-ANPP, 4-Fluoroisobutyrl fentanyl, Acetyl fentanyl, 
Acrylfentanyl, Carfentanil, Despropionyl para-Fluorofentanyl, Fentanyl, Furanyl fentanyl, 
Methoxyacetyl fentanyl, Norfentanyl, U-47700, Valeryl fentanyl, Morphine, Codeine, 
Oxycodone, Hydrocodone, 6-monoacetylmorphine, Amphetamine, Ethylmorphine, 
Methamphetamine, Benzoylecgonine, Norbuprenorphine, Buprenorphine, and Methadone 
standards, as well as, D5-Norfentanyl, D5-Fentanyl, D5-Acryl fentanyl, D5-Furanyl fentanyl, D5-
Carfentanil, D6-U-47700, and D5-Valeryl fentanyl internal standards were purchased from 
Cerilliant (Round Rock, TX).  
 
Methanol (Optimaâ), formic acid (Optimaâ), Ammonium formate, Methylene chloride 
(Optimaâ), 2-propanol (Optimaâ), concentrated Hydrochloric acid (Trace grade) and 
concentrated Ammonium hydroxide were purchased from Fisher Scientific (Fair Lawn, NJ). 
Monobasic sodium phosphate, dibasic sodium phosphate, sodium hydroxide, and potassium 
chloride were purchased from Sigma-Aldrich (St. Louis, MO). A Millipore Direct-Qâ UV water 
purification system (Billerica, MA) was used to obtain purified water (18.2 MW). Bond Elut 
Certify, 130 mg 3 mL solid-phase extraction (SPE) cartridges were obtained from Agilent (Santa 
Clara, CA). The oral fluid was provided by non-opioid using volunteers through expectoration and 
was pooled (n = 7) for use with the confirmatory method validation. Blank matrix was analyzed 




An Agilent 1290 Infinity II Liquid Chromatography system with an Agilent 6470 Triple 
Quadrupole Mass Spectrometer (Santa Clara, CA) was utilized for confirmatory analysis with 
Agilent MassHunter software. Solid-phase extraction was performed utilizing a Positive Pressure 
Manifold from UCT (Bristol, PA). 
 
2.3 Preparation of Standard Working Solutions 
 
Stock solutions of standards and internal standards (ISTD) were prepared in methanol to 
100 µg/mL or 10 µg/mL. Methanolic calibrator solutions were prepared to 0.1, 0.5, 1, 5, 10, 25, 
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and 50 ng/mL containing all standards. ISTD concentration was prepared at 25 ng/mL in calibrator 
samples. Negative controls were prepared with only ISTD. All standard solutions were stored at -
20 °C in amber vials.  
 
2.4 Extraction Procedure 
 
Fortification or spiking of the mix of standard solutions was utilized to achieve the desired 
concentrations. ISTD was spiked into the oral fluid samples to achieve 25 ng/mL. Cartridges were 
conditioned with 1 mL of methanol followed by 1 mL of water then 1 mL of 10 mM phosphate 
buffered saline (PBS) supplemented with 100 mM KCl. The oral fluid was loaded onto the column 
for a final volume of 100 µL. The column was dried under approximately 20 psi nitrogen for 3-5 
minutes. Elution was then carried out using 1 mL of methylene chloride:isopropyl 
alcohol:ammonium hydroxide (78:20:2). The eluted volume was then evaporated under nitrogen 
at approximately 45 °C. The samples were reconstituted in 100 µL of mobile phase A:mobile phase 
B (95:5). A total of 1 µL was injected on the LC/MS/MS. 
 
2.5 Liquid Chromatography 
 
Chromatographic separation was completed using an Agilent RR-HD Zorbax Eclipse Plus 
C18 column (3.0 x 100 mm, 1.8 microns) with an Agilent SB-C18 pre-column (3.0 x 5 mm, 1.8 
microns). The column temperature was maintained at room temperature. A gradient elution at 0.5 
mL/min with a 0.1% formic acid and 5 mM ammonium formate in water (mobile phase A) and 
0.1% formic acid in methanol (mobile phase B) was used to achieve separation (Table 6). 
 
Table 6: Gradient elution for chromatography 
Time (min) A (%) B (%) 
0.00 95 5 
1.00 95 5 
8.50 5 95 
 
 
2.6 Mass Spectrometry 
 
Dynamic multiple reaction monitoring (dMRM) was used for data acquisition in positive 
mode electrospray ionization. A minimum of two transitions per analyte and internal standard were 
used for analysis (Table 7). Source parameters were optimized using MassHunter Source 
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Optimizer and were as follows: gas temperature 325 °C, gas flow 5 L/min, nebulizer 25 psi, sheath 
gas temperature 350 °C, sheath gas flow 11 L/min, and capillary voltage 3500 V. 
 





 This method was validated following the recommendations from the American Academy 
of Forensic Science Standards Board (ASB). Linearity was determined using seven non-zero 
calibrators. The lowest limit of quantitation (LLOQ) was evaluated as the lowest non-zero 
calibrator analyzed a total of six times. The limit of detection was determined through serial 
dilution and evaluated based on signal-to-noise for identification of the quantifier ion. Bias and 
precision were assessed in pooled oral fluid samples through spiking during SPE. Low (0.5 
ng/mL), medium (5 ng/mL), and high (25 ng/mL) concentrations were assessed in triplicate over 















Energy (V) Internal Standard 
Norfentanyl 5.57 233 – 84 233 – 150 
233 – 55 
107 20, 20,44 D5-Norfentanyl 
Methoxy acetyl 
fentanyl 
6.00 353 – 188 353 – 105 
353 – 77 
92 24, 44, 108 D5-Fentanyl 
Acetyl Fentanyl 6.13 323 – 105 323 – 188 
323 – 77 
98 44, 24, 96 D5-Fentanyl 
4-ANPP 6.41 281 – 105 281 – 188 122 36, 16 D5-Fentanyl 
      
Acryl Fentanyl 6.49 335 – 105 335 – 188 
335 – 77 
94 44, 24, 94 D5-Acryl fentanyl 
Despropionyl para- 
fluorofentanyl 
6.54 299 – 188 299 – 105 
299 – 77 
98 20, 40, 88 D5-Fentanyl 
Furanyl Fentanyl 6.57 375 – 188 375 – 105 146 24, 48 D5-Furanyl fentanyl 
   
Fentanyl 6.61 337 – 188 337 – 105 146 24, 48 D5-Fentanyl 
   
Carfentanil 6.75 395 – 335 395 – 113 
395 – 105 
136 16, 36, 56 D5-Carfentanil 
2’-fluoro ortho- 
fluorofentanyl 
6.81 373 – 206 373 – 123 
373 – 103 
106 28, 48, 64 D5-Fentanyl 
U-47700 6.89 329 – 173 329 – 145 
329 – 109 
86 36, 64, 88 D6-U-47700 
FIBF 7.04 369 – 188 369 – 105 
369 – 77 
92 28, 48, 108 D5-Fentanyl 
Valeryl Fentanyl 7.43 365 – 188 365 – 105 
365 – 77 
100 28, 48, 108 D5-Valeryl fentanyl 
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concentrations through analysis of sets A, B and C. Set A consisted of neat methanolic samples 
spiked with standard and ISTD to the desired concentration. Set B consisted of extracted oral fluid 
samples spiked with standard and ISTD during reconstitution. Set C consisted of extraction of 
spiked oral fluid samples.  
A low and high for set A were each injected a total of 6 times. Sets B and C were analyzed 
in duplicate with ten replicates each (replicates 1-7 were individual oral fluid matrix, while 
replicates 8-10 were pooled matrix from the seven donors). Matrix effects, recovery, and process 
efficiency were assessed as described in equations 5, 6, and 7. Interferences were evaluated by 
analyzing twelve additional common drugs at 1 µg/mL in methanolic solution. The drugs tested 
were: Morphine, Codeine, Oxycodone, Hydrocodone, 6-monoacetylmorphine, Amphetamine, 
Ethylmorphine, Methamphetamine, Benzoylecgonine, Norbuprenorphine, Buprenorphine, and 
Methadone. Carryover was assessed through the use of a negative QC sample immediately 
following the highest calibrator in every run. Processed sample stability was assessed for three 
freeze/thaw cycles using fortified matrix. Autosampler stability was assessed at room temperature 
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3.1 Chromatographic Separation 
 
 Chromatographic separation was achieved through the use of the developed dMRM 
method. No isobaric interferences were present, and acceptable peak resolution was achieved. 





Figure 35: Chromatographic separation of analytes of interest using dMRM. 
 
 
3.2 LC/MS/MS Method Validation 
 
The calibration model was determined to be linear, and all analytes had an R2 value that 
was ³ 0.9992.  Weighting of 1/x was utilized for the calibration range between 0.1 and 50 ng/mL. 
LODs were within ASB recommendation with signal-to-noise ratios of the quantifying ion greater 
than 3 at 0.01 ng/mL for the majority of drugs. LLOQs were within ASB recommendations with 
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Table 8: Linearity, limit of detection (LOD), and lowest limit of quantitation (LLOQ) for the analytes 
 
 Bias and precision data are summarized in Table 9. Bias ranged between -15 to 6% for the 
low, -15 to 0.5% for the medium, and -11 to 6% for the high concentration except for Acetyl 
fentanyl and Methoxyacetyl fentanyl. Within-run precision was calculated as the percent 
coefficient of variation (%CV) and ranged from 4 to 24% for the low, 4 to 25% for the medium, 7 
to 31% for the high concentration. Several drugs were above the acceptable 20% CV (4-ANPP, 
Despropionyl para-fluorofentanyl at medium and high, Methoxyacetyl fentanyl at high, and 
Norfentanyl at low and medium). Between-run precision was assessed as %CV and ranged from 
6 to 23% for the low, 4 to 20% for the medium, and 5 to 23% for the high concentration. Two 
drugs were above the acceptable 20% CV (Despropionyl para-fluorofentanyl for low and high and 






Analyte y-intercept  
(mean ± SD, n = 5) 
Slope            
(mean ± SD, n = 5) 
R2 range 





Norfentanyl 0.0081 ± 0.0038 0.0403 ± 0.0011 0.9999 – 
0.9994  
0.01 0.1 
Methoxyacetyl fentanyl 0.0056 ± 0.0039 0.0319 ± 0.0010 0.9999 – 
0.9994 
0.01 0.1 
Acetyl Fentanyl 0.0047 ± 0.0038 0.0313 ± 0.0013 0.9999 – 
0.9995 
0.01 0.1 
4-ANPP 0.0092 ± 0.0075 0.0531 ± 0.0013 0.9999 – 
0.9993 
0.01 0.1 
Acryl Fentanyl 0.0105 ± 0.0057 0.0479 ± 0.0014 0.9999 – 
0.9993 
0.01 0.1 
Despropionyl para-fluorofentanyl 0.0055 ± 0.0049 0.0437 ± 0.0012 0.9999 – 
0.9993 
0.01 0.1 
Furanyl Fentanyl 0.0118 ± 0.0089 0.0633 ± 0.0024 0.9999 – 
0.9995 
0.1 0.5 
Fentanyl 0.0071 ± 0.0057 0.0375 ± 0.0013 0.9999 – 
0.9992 
0.01 0.1 
Carfentanil 0.0103 ± 0.0077 0.0614 ± 0.0019 0.9999 – 
0.9994 
0.1 0.5 
2’-fluoro ortho-fluorofentanyl 0.0067 ± 0.0039 0.0342 ± 0.0011 0.9999 – 
0.9994 
0.01 0.1 
U-47700 0.0068 ± 0.0024 0.0366 ± 0.0009 0.9998 – 
0.9993 
0.01 0.1 
FIBF 0.0047 ± 0.0037 0.0251 ± 0.0009 0.9999 – 
0.9992 
0.01 0.1 
Valeryl Fentanyl 0.0094 ± 0.0055 0.0498 ± 0.0013 0.9999 – 
0.9996 
0.01 0.1 
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Table 9: Bias and precision data for the analytes tested 
Analyte Accuracy, Bias (%) (n = 15)  
Within-run Precision 
(%CV) (n = 3)  
Between-run Precision 
(%CV) (n = 15) 
 LOW MED HIGH  LOW MED HIGH  LOW MED HIGH 
2’fluoro ortho-
fluorofentanyl 5.4 -3.0 -8.1  16 11 12  9.4 7.9 10 
4-ANPP -7.4 -5.4 6.1  24 21 29  19 17 19 
4-Fluoroisobutyrl fentanyl -7.4 -11 -11  4.1 5.5 10  6.4 3.9 7.9 
Acetyl fentanyl 33 23 27  13 12 17  11 8.4 9.1 
Acryl fentanyl 3.5 -0.6 -0.7  8.0 4.3 7.3  7.5 4.2 4.6 
Carfentanil 5.4 -0.2 -1.9  13 6.7 8.5  9.9 4.7 6.0 
Despropionyl para-
fluorofentanyl -13 -15 -1.4  14 25 31  23 19 23 
Fentanyl 4.3 -0.3 -1.2  16 5.8 9.1  9.9 3.9 5.6 
Furanyl fentanyl 3.3 -1.3 -2.6  11 5.5 6.9  6.3 4.3 5.1 
Methoxy acetyl fentanyl 44 33 40  13 15 26  11 11 14 
Norfentanyl -15 -7.4 3.7  22 21 18  16 20 12 
U-47700 0.3 0.5 -0.8  11 9.5 9.1  9.0 6.0 6.3 
Valeryl fentanyl 5.9 -1.5 -3.0  14 11 11  10 5.8 6.1 
a Data in % 
LOW = 0.5 ng/mL, MED = 5 ng/mL, HIGH = 25 ng/mL 
 
 
Matrix effects, recovery, and process efficiency are presented in Table 10. All analytes 
were within the required ±25% for matrix effects with the exception of Despropionyl para-
fluorofentanyl. However, Depropionyl para-fluorofentanyl was shown to have an acceptable bias 
at low, medium, and high concentrations, although precision suffered slightly. Recovery was 
greater than 87% for all analytes. Process efficiency was above 71% for all analytes and above 
80% for analytes that met matrix effect parameters. Matrix effects were, in general, positive, 
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Table 10: Matrix effect, recovery, and process efficiency for analytes tested 
Compound Matrix Effectsa  Recovery  Process Efficiency 
 LOW  HIGH  LOW  HIGH  LOW  HIGH 
 Meanb  Mean  Mean  Mean  Mean  Mean 
2’fluoro ortho-
fluorofentanyl -3.0  -6.5  90  89  87  84 
4-ANPP -15  -22  116  125  99  98 
4-Fluoroisobutyrl 
fentanyl -12  -8.0  96  87  85  80 
Acetyl fentanyl 19  15  107  107  127  123 
Acryl fentanyl 1.1  0.8  96  97  97  97 




-27  -31  98  114  71  79 
Fentanyl 1.1  0.6  100  100  101  100 
Furanyl fentanyl 0.02  0.06  101  97  101  97 
Methoxy acetyl 
fentanyl 25  21  110  110  137  134 
Norfentanyl 3.0  1.2  105  105  109  107 
U-47700 -2.7  -0.6  106  103  103  103 
Valeryl fentanyl -0.7  1.6  105  96  104  97 
a Matrix effects calculated based on ASB guidelines: 0% is no effect 
b Data in %, n = 10 
LOW = 0.5 ng/mL, HIGH = 5 ng/mL 
       
 
 Selectivity and interference were assessed through the analysis of other drugs of abuse 
commonly encountered in the forensic laboratory. No interference with the target analytes was 


















Figure 36: Chromatographic separation of 25 drugs of abuse, including the 13 target analytes. 
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Freeze/Thaw stability was assessed for three freeze/thaw cycles. Relative response to the 
internal standard was used to compare to the time zero samples. Pooled, fortified oral fluid was 
aliquoted and tested for time zero and frozen for 24 hours. Unassisted thaw at room temperature 
was used to thaw the samples prior to analysis. All analytes were stable within 20% of time zero, 
except for 4-ANPP and Despropionyl para-fluorofentanyl (at the high concentration). 2’-fluoro 
ortho-fluorofentanyl (at the high concentration), Furanyl fentanyl (at the low concentration), 
Methoxyacetyl fentanyl, and Valeryl fentanyl (at the low concentration) fell outside the 20% 
threshold before 72 hours. Table 11 shows the stability of the analytes through three freeze/thaw 
cycles over 72 hours, assessed as the percent difference from time zero.  
 
Table 11: Freeze/thaw stability for three cycles over 72 hours for pooled fortified matrix 
Compound Thaw 1  Thaw 2  Thaw 3 
 LOW  HIGH  LOW  HIGH  LOW  HIGH 
 Mean  Mean  Mean  Mean  Mean  Mean 
2’fluoro ortho-
fluorofentanyl -9.6  3.7  -1.8  28  -0.6  21 
4-ANPP -31  -47  -21  -37  -27  -49 
4-Fluoroisobutyrl 
fentanyl -8.7  0.1  -3.2  18  5.9  3.5 
Acetyl fentanyl -4.7  -17  -7.0  -19  -10  -19 
Acryl fentanyl -5.3  0.09  -1.8  7.1  -0.2  -0.5 




-7.7  -47  9.2  -35  4.2  -49 
Fentanyl 2.9  -3.6  6.1  1.0  3.4  -3.5 
Furanyl fentanyl -15  -3.2  -19  2.1  -21  -6.7 
Methoxy acetyl 
fentanyl -7.0  -20  -16  -26  -18  -24 
Norfentanyl -7.6  -0.09  -9.4  7.8  4.8  10 
U-47700 -10  -11  -7.1  -3.0  -13  -5.2 
Valeryl fentanyl -16  -5.0  -19  -1.8  -28  -6.0 
Data in % difference from time = 0, n = 3 
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Processed sample stability was assessed at room temperature storage in the autosampler 
and storage at -20°C for 24, 48, and 72 hours as the percent difference from time zero (Tables 12 
and 13). Again, 4-ANPP and Despropionyl para-fluorfentanyl were not stable as processed 
samples in 100 µL, and Acryl fentanyl (at the low concentration) was not stable at the 72-hour 
mark at room temperature. Furanyl fentanyl and Valeryl fentanyl fell outside of 20% for the low 
concentration at 48 hours but were below 20% at 72 hours. Therefore, it was considered that these 
analytes were stable. All analytes were stable for 72 hours with freezer storage at -20°C except 
Despropionyl para-fluorofentanyl (at the low concentration). Plots demonstrating the stability of 
all 13 analytes under the various conditions can be found in Figure 37. Individual analyte stability 
plots can be found in the appendix, which demonstrate the stability of each analyte along with the 
±20% threshold lines (Figures A5-A7). 
 
Table 12: Room temperature autosampler stability of analytes for processed samples over 72 hours in the 
fortified, pooled matrix 
Compound 24 hours  48 hours  72 hours 
 LOW  HIGH  LOW  HIGH  LOW  HIGH 
 Meanb  Mean  Mean  Mean  Mean  Mean 
2’fluoro ortho-
fluorofentanyl 3.3  11  12  2.7  6.2  6.7 
4-ANPP -21  -24  -26  -27  -51  -28 
4-Fluoroisobutyrl 
fentanyl 1.5  -2.4  14  -3.7  -2.3  -6.4 
Acetyl fentanyl -3.5  -8.9  -1.2  -7.1  0.9  -7.0 
Acryl fentanyl 1.0  -1.0  -0.9  -0.3  -32  1.0 




3.3  -28  -7.0  -29  -38  -34 
Fentanyl 4.9  -3.5  4.8  -5.1  5.5  -4.0 
Furanyl fentanyl -6.9  -0.1  -32  -3.4  -9.8  -0.6 
Methoxy acetyl 
fentanyl 0.07  -6.8  -0.9  -4.0  6.3  -3.6 
Norfentanyl -3.0  -2.0  -4.4  -0.9  -4.6  -1.8 
U-47700 -3.7  -1.3  -3.4  0.08  -8.7  -6.5 
Valeryl fentanyl -19  -2.7  -27  -3.9  -19  -5.3 
Data in % difference from time = 0, n = 3 
LOW = 0.5 ng/mL, HIGH = 5 ng/mL        
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Table 13: Freezer stability of analytes for processed samples over 72 hours in the fortified, pooled matrix 
Compound 24 hours  48 hours  72 hours 
 LOW  HIGH  LOW  HIGH  LOW  HIGH 
 Meanb  Mean  Mean  Mean  Mean  Mean 
2’fluoro ortho-
fluorofentanyl 8.2  2.6  11  2.0  8.8  3.3 
4-ANPP -13  -7.8  -19  -10  19  -8.9 
4-Fluoroisobutyrl 
fentanyl 4.7  -4.1  0.07  -13  13  -9.0 
Acetyl fentanyl 1.9  3.9  1.3  5.9  6.9  8.7 
Acryl fentanyl -1.9  -0.3  2.0  -0.5  0.4  0.6 




-47  -15  -45  -20  -93  -20 
Fentanyl -1.3  -2.1  -2.6  -2.4  2.0  -1.7 
Furanyl fentanyl -0.2  -0.3  4.7  -1.4  -1.7  -0.6 
Methoxy acetyl 
fentanyl 7.2  8.8  11  13  16  15.6 
Norfentanyl 1.8  -0.2  -1.4  0.9  3.9  1.9 
U-47700 -8.9  1.9  -7.5  4.7  -0.5  4.1 
Valeryl fentanyl -6.6  1.5  -9.1  3.1  5.9  2.5 
Data in % difference from time = 0, n = 3 






Figure 37: Graphical depiction of the stability of all analytes over 72 hours for freeze/thaw (a), 
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Chromatographic separation was achieved for the panel of target drugs without interference 
from common drugs of abuse. Several regions of slight co-elution were observed but did not pose 
any issue as the precursor ions were different. Limits of detection were determined by serial 
dilution of a standard mix and the assessment of a minimum of 5 calibration curves. The LODs 
were determined to be 0.01 ng/mL for all target analytes except Carfentanil and Furanyl fentanyl, 
which had LODs between 0.01 ng/mL and 0.1 ng/mL. The majority of the analytes were within 
acceptable bias and precision limits as specified by the ASB Standard 036.65 A solid-phase 
extraction protocol was explored using spiked oral fluid samples. The wash step was eliminated 
and resulted in an average recovery for the fentanyl analogs of 102%. Lastly, stability was assessed 
over three freeze/thaw cycles, 72 hours of processed freezer storage, and 72 hours of processed 
autosampler storage. The majority of analytes were shown to be stable under all conditions. 
 
4.2 Future Work 
 
Future work on detection of fentanyl using the LC/MS/MS method will include the analysis 
of more fentanyl analog compounds to expand the method and detection capabilities. Work should 
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1.1 Overall Conclusions  
 
 This thesis demonstrated the use of an electrochemical detection method for fentanyl 
capable of performing detection measurements in cell and on small sample sizes such as a drop. 
This approach represents a fast, simple, and cost-effective strategy for the detection of fentanyl in 
seized drug samples or unknowns. Detection capability was shown to be achieved in the low parts-
per-billion range with minimal interferences from other commonly encountered drugs. The 
electrochemical method demonstrates excellent promise for the detection of not only fentanyl, but 
other illicit drugs as well. 
 An LC/MS/MS method was also presented for the confirmatory analysis of fentanyl and 
its analogs in oral fluid. This dMRM method followed validation protocol to describe the 
identification and quantitation of 13 fentanyl and fentanyl-related compounds, at sub-parts-per-
billion levels, without interference from other commonly analyzed drugs. Use of the oral fluid 
matrix is desirable due to the non-invasive collection of the sample and information regarding 
recent drug use.  
Together the two methods represent an identification method for fentanyl that could be 
utilized within the laboratory or in the field with the capability of performing quasi-quantitation 
and a confirmatory method through liquid chromatography-tandem mass spectrometry, validated 
for use in oral fluid samples. The combined use of these techniques seeks to emulate the 
SWGDRUG requirement for a category A with a category A, B, or C technique, although 
electrochemistry has, to this point, not been included in the list of acceptable techniques. This 
thesis seeks to advance the scientific knowledge regarding the detection of fentanyl and the use of 
electrochemistry for the detection of drugs of abuse. Implementation of electrochemical techniques 
in laboratories or in the field could provide a solution to reducing the backlog of cases due, in part, 
to the opioid epidemic within the country, and could provide a more cost-effective and 
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 Several other electrochemical methods were employed during the course of this study to 
either become more proficient at the techniques and methods utilized, to attempt detection of 
fentanyl using another electrochemical method, or for the analysis of different compounds. These 
methods are summarized in brief within this chapter. 
 
1.1 Enzymatic Biosensor for the Detection of Codeine in Preparation for Fentanyl 
 
 The development of an enzymatic biosensor for fentanyl was initially investigated based 
on reports of enzymatic modifications providing excellent sensitivity and selectivity for their target 
analytes. Initial work focused on the reproduction of a codeine sensor developed by colleagues in 
Spain using cytochrome P450 2D6 (CYP2D6).19 The work then focused on the development of a 
fentanyl sensor using SPEs modified with cytochrome P450 3A4 (CYP3A4).  
 
1.1.1 Materials and Methods 
 
 Codeine was purchased from Cayman Chemical Company (Ann Arbor, MI). 200 proof 
ethanol was purchased from Decon Laboratories. Acetonitrile (Optimaâ) was purchased from 
Fisher Scientific (Fair Lawn, NJ). Sodium hydroxide, potassium chloride, 4-
nitrobenzenediazonium tetrafluoroborate salt, tetrabutylammonium tetrafluoroborate, N-
hydroxysuccinimide (NHS), N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide (EDC), 
Monobasic sodium phosphate, and dibasic sodium phosphate were purchased from Sigma Aldrich 
(St. Louis, MO). Cytochrome P450 2D6 was purchased from U.S. Biological. 
 
Screen-printed carbon electrodes (SPCEs) were obtained from the Universidad de Burgos 
analytical chemistry department. SPCEs were fabricated using a DEK 248 screen-printing system 
(DEK, Weymouth, UK) with polyester screens with stencils. SPCEs contained conductive silver 
tracks, Ag/AgCl pseudo-reference electrode, and carbon working (0.126 cm2) and counter 
electrodes.  
 
A 4 mM diazonium salt solution was prepared by adding 4-nitrobenzenediazonium 
tetrafluoroborate to 100 mM tetrabutylammonium tetrafluoroborate in acetonitrile. A 9:1, 
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water:ethanol mixture was prepared and supplemented with 100 mM KCl. A solution of 40 mM 
NHS as well as a solution of 80 mM EDC was prepared in 10 mM phosphate buffer pH 4. Lastly, 
100 mM phosphate buffer pH 7 was prepared and used as the supporting electrolyte. 
 
Modification of SPCEs through covalent attachment of CYP2D6 for analysis of codeine 
was performed in a 3-step immobilization procedure. A self-assembling monolayer (SAM) was 
created through the addition of a 50 µL drop of the diazonium salt solution Cyclic voltammetry 
was then performed between 800 mV and -400 mV at a scan rate of 200 mV/sec. for two cycles. 
A 100 uL drop of 9:1 (water:ethanol) was placed on the electrode surface followed by cyclic 
voltammetry between 0 V and -1700 mV at a rate of 200 mV/sec. for two cycles. Lastly, the 
electrode was washed with the pH 4 phosphate buffer and 0.5 to 1 µL of the CYP2D6 enzyme 
solution was placed on the working electrode followed by 2 µL of NHS and 1 µL of EDC. The 
electrode was then left at 4°C for 90 minutes. These concentrations and volumes were adjusted to 




Figure 38: Covalent attachment strategy via self-assembled monolayer for CYP2D6 on carbon surface of 
SPCE. 
 
 Codeine (1 mg) was prepared in 100 mM phosphate buffer pH 7 to a stock solution of 1 
mg/mL (1000 µg/mL). Further concentrations were prepared as needed. Analysis of codeine was 
conducted in a 5 mL electrochemical cell containing 100 mM phosphate buffer pH 7 and as a drop 
on the electrode surface using chronoamperometry through the application of 200 mV in a stirred 
solution. After allowing the background current to equilibrate, standard additions of codeine were 
added to the cell at equal time intervals and the current was recorded. Analysis of codeine was also 













Electrochemical measurements were carried out using the PalmSens4 potentiostat with 
PSTrace software (Randhoeve, Netherlands) and Autolab PGSTAT with NOVA software from 
Metrohm (Ionenstrasse, Switzerland). Measurement of solution pH was achieved using a Mettler 
Toledo FiveEasy Plus pH meter (Columbus, OH). A Millipore Direct-Qâ UV water purification 
system (Billerica, MA) was used to obtain purified water. 
 
1.1.3 Results and Discussion 
 
 The first step in the covalent attachment of the enzyme represents the attachment of the 
diazonium salt to the carbon working electrode. This was followed by the reduction of the nitro 
groups to amine groups allowing for the covalent attachment of the enzyme to the amine group. 
The resulting cyclic voltammograms for the attachment can be seen in Figure 38. These were in 
partial agreement with the literature. Where the literature suggests that there should be a large 
reduction peak resulting from the nitro group reduction around -1.2 V, only a small wave was 
observed. The enzyme modification was checked using cyclic voltammetry in the supporting 
electrolyte and was found to be different than presented in the literature, although for a different 
CYP enzyme (Figure 39).17 This could reflect a problem encountered during the covalent 
attachment of the enzyme, suggesting that the enzyme may not be adequately bound or is missing.   
 
 
Figure 39: Attachment to the diazonium salt to the working electrode surface (left) and reduction of the 

















































Figure 40: Cyclic voltammetry in PBS buffer demonstrating the difference between the blank SPCE and 
the enzyme-modified SPCE. 
 
It was determined that there was too much noise present in measurements utilizing our 
instrumentation within the lab. This could have been due to the magnetic stir plate or several other 
instruments etc. drawing power from the building. Therefore, it was impractical to perform the 
analysis in a stirred solution. It was determined that analysis could be performed in a drop on the 
electrode surface through standard addition. Through the addition of codeine, it appeared that a 
current response was observed. Codeine was analyzed between 3.5 µg/mL and 15.5 µg/mL and 
resulted in a linear relationship with a coefficient of determination of 0.9872. However, there were 
concerns regarding the shape of the resulting chronoamperogram as each step current continued a 
constant decrease in current (Figure 40). 
 
 
Figure 41: Chronoamperogram for the standard addition of 20 µL of 30 µg/mL codeine to a 150 µL drop 
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1.2 Enzymatic Biosensor for the Detection of Fentanyl 
 
 Due to CYP3A4 being implicated as the major CYP mediated metabolic pathway for 
fentanyl, an exploration into the use of CYP3A4 for the detection of fentanyl using screen-printed 
electrodes was performed. Immobilization of the enzyme was attempted through the modification 
of a procedure described by Joseph et al.,81 as well as, covalent attachment using the previously 
mentioned diazonium salt technique.  
 
1.2.1 Materials and Methods 
 
Fentanyl citrate was purchased from Cayman Chemical Company (Ann Arbor, MI). 
Ethanol 200 proof was purchased from Decon Laboratories. Glycerol was purchased from MP. 
Sodium hydroxide, 3-mercapto-1-propanesulfonic acid (MPS), poly-(diallyldimethylammonium 
chloride) 20% wt. (PDDA), potassium chloride, monobasic sodium phosphate, and dibasic sodium 
phosphate were purchased from Sigma Aldrich (St. Louis, MO). Cytochrome P450 3A4 was 
purchased from Aviva Systems Biology at 1 mg/mL. 
 
A 1 mM MPS solution was prepared in 18.2 MW water. A 2 mg/mL solution of PDDA was 
prepared in 18.2 MW water. An electrode cleaning solution was prepared at a 60:39:1 ratio of 
ethanol:water:NaOH. A 50 mM phosphate buffer supplemented with 100 mM KCl (PBS) was 
prepared and used to prepare a solution of CYP3A4. Enzyme preparation was completed by 
aliquoting 1.5 µL of enzyme solution with 1.5 µL 100 mM PBS pH 7 into a PCR tube and frozen. 
Before use, one tube was removed and thawed unassisted at room temperature and 4 µL of 6.2% 
glycerol solution was added. The fentanyl solution was prepared from fentanyl citrate in PBS 
solution. To this end, 2 mL of PBS was added to a vial containing 10 mg of fentanyl citrate for a 
concentration of 3125 µg/mL fentanyl. From this stock solution, concentrations of 0.5, 1, 2, 4, 6, 
8, 10, 50, and 100 µg/mL were made in PBS. A 50 mM phosphate buffer supplemented with 100 
mM sodium nitrate (PBS/NO3) was prepared. 
 
Screen-printed gold electrodes (SPAuEs) were obtained from the Universidad de Burgos 
analytical chemistry department. SPCEs were fabricated using a DEK 248 screen-printing system 
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(DEK, Weymouth, UK) with polyester screens with stencils. SPCEs contained conductive silver 
tracks, Ag/AgCl pseudo-reference electrode, gold working electrode (0.126 cm2), and carbon 
counter electrode. 
 
 Prior to the immobilization of the enzyme, the gold working electrode was first cleaned by 
placing a drop of the 60:39:1 cleaning solution on the electrode and allowing it to sit for 30 seconds 
to a minute before being polished with an alumina slurry. Immobilization was achieved by placing 
a drop of the MPS solution on only the working electrode. This drop was allowed to evaporate or 
was dried under nitrogen. A drop of PDDA was then placed on the working electrode for 20 
minutes before being rinsed and dried under a stream of nitrogen. Experiments were also 
conducted by allowing the PDDA solution to dry thoroughly on the electrode surface. Finally, a 
1.5 µL drop of the enzyme/glycerol solution was placed on the electrode surface for 20 minutes 
before being rinsed and dried under nitrogen. Again, allowing the enzyme solution to dry 




Figure 42: Immobilization strategy via self-assembled monolayer for CYP3A4 on the gold surface of the 
SPAuE. 
 
 Amperometric measurement of fentanyl was performed in a 100 µL drop of fentanyl and 
supporting electrolyte on the surface of the enzyme-modified gold electrode (SPAu/CYPE). To this 
end, a potential of -450 mV was applied for 60 seconds. Each concentration, including a buffer 






















































Electrochemical measurements were carried out using the PalmSens4 potentiostat with 
PSTrace software (Randhoeve, Netherlands) and the Autolab PGSTAT with NOVA software from 
Metrohm (Ionenstrasse, Switzerland). Measurement of solution pH was achieved using a Mettler 
Toledo FiveEasy Plus pH meter (Columbus, OH). A Millipore Direct-Qâ UV water purification 
system (Billerica, MA) was used to obtain purified water. 
 
1.2.3 Results and Discussion 
 
 Several problems encountering noise were observed when attempting to perform 
amperometric detection in a cell with stirring. Furthermore, the resulting chronoamperograms did 
not demonstrate a current response to fentanyl in an observable and reproducible way. Therefore, 
an amperometric analysis was carried out as a drop on the surface of the electrode. To this end, a 
chosen time of 60 seconds was used for the analysis of fentanyl following a similar amperometric 
approach as described in the literature.82,83 Analysis was carried out between fentanyl 
concentrations of 0.5 µg/mL and 100 µg/mL. Acceptable linearity was observed with an average 
RSD of 17% across the concentration range (Figure 42).  
 
 
Figure 43: Constructed chronoamperograms for fentanyl detection at a SPAuE in a 100 µL drop of 50 mM 
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 Attempts were made to characterize the surface of the modified electrode in order to 
determine that the modification procedure was achieved before the immobilization of the CYP3A4 
enzyme. Scanning electron microscopy-energy dispersive X-ray spectroscopy (SEM-EDS) was 
used for imaging and elemental analysis of the surface. Elemental analysis of a bare SPAuE 
demonstrated peaks due to the presence of gold, analysis of the MPS modified electrode 
(SPAu/MPSE) demonstrated the presence of sodium and a shoulder in the large gold peak 
corresponding to sulfur. As shown in the structure of MPS and outlined in the literature,61 Both 
sulfur and sodium are present in the structure, suggesting the presence of the MPS self-assembled 
monolayer on the surface of the gold electrode. Lastly, the electrode surface of the MPS/PDDA 
modified electrode was analyzed (SPAu/MPS/PDDAE). The loss of the presence of sodium 
demonstrates the negative charge on the MPS layer allowing for positively charged PDDA 
molecule. The presence of chlorine may be attributed to the counter ion of PDDA; however, there 
was evidence of chlorine in the MPS modified electrode as well, but the peak was more 
pronounced in the PDDA layer. Figure 43 demonstrates the acquired SEM-EDS spectra.  
 
 
Figure 44: SEM-EDS spectra for a bare SPAuE (left), MPS modified SPAu/MPSE (middle), and PDDA 
modified SPAu/MPS/PDDAE (right). 
 
 The use of both SEM and atomic force microscopy (AFM) was used to attempt to visualize 
and characterize the electrode surface as well. Little to no difference was observed between the 
modification steps of the electrode with SEM of AFM. The gold surface of the SPAuE was observed 
to be tightly packed spherical particles at high magnification and at low magnification, surface 
imperfections were visible on the working electrode (Figure 44). AFM was not useful in discerning 
surface differences due to the modification of the electrode. AFM images plotting height can be 
























































































































































Figure 45: SEM images for the blank SPAuE (a and b), the MPS modified electrode (c), and the 














Figure 46: AFM images plotting the height of the blank SPAuE (a), MPS modified electrode (b), and 
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 Although it was initially observed to demonstrate a response to fentanyl, this method was 
not appropriate due to the determination that the signal was from chloride in solution. Upon further 
investigation of the amperometric sensor, it was discovered that the current response was likely 
due to chloride ion in the PBS buffer and not to fentanyl itself. This lack of signal for fentanyl 
could be due to loss of the enzyme from the electrode into the solution, loss of conformation of 
the enzyme resulting in lost activity, too small an enzyme concentration, or inappropriate potential 
applied. Later experiments performed using square-wave voltammetry demonstrated the oxidation 
of fentanyl at a positive potential. However, the potential applied to the enzyme-modified electrode 
was required for the electron transfer with the enzyme and was not directly involved in the electron 
transfer with fentanyl. The potential applied was similar to what is found in the literature for CYP 
3A4.84–86 Failure of this method prompted exploration into other methods for the detection of 
fentanyl using screen-printed carbon electrodes. Although the use of only PBS supplemented with 
nitrate was attempted, signal response to fentanyl could not be confirmed and this method as 
abandoned for detection of fentanyl. 
 
1.3 Detection of the Synthetic Cannabinoid PB-22 
 
 The detection of PB-22 was investigated to explore electrochemical methods for the 
detection of synthetic cannabinoids. The redox process of PB-22 was explored using a 
conventional platinum electrode following a modified procedure by Dronova et al.87  
 
1.3.1 Materials and Methods 
 
 PB-22 was purchased as neat solid from Cayman Chemical (Ann Arbor, MI). Conventional 
platinum working and auxiliary electrodes and a Ag/AgCl reference electrode were purchased 
from Metrohm (Ionenstrasse, Switzerland). Tetrabutylammonium perchlorate (TBAP) was 
purchased from Acros Organics (Fair Lawn, NJ). Acetonitrile (Optima®), Methanol (Optima®), 
and sulfuric acid (Trace Metal Grade) were purchased from Fisher Scientific (Fair Lawn, NJ). 
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 Supporting electrolyte was prepared as 10 mM TBAP in acetonitrile. PB-22 was prepared 
by dissolving 5 mg of neat solid in 10 mL of methanol for a final concentration of 500 µg/mL. A 
solution of 0.5 M sulfuric acid was prepared from concentrated. The platinum working electrode 
was polished using alumina powder and water in figure-eights in both directions for 30-60 seconds. 
Following a brief rinsing of the electrode with water, it was electrochemically cleaned in 0.5 M 
sulfuric acid using cyclic voltammetry between -0.21 V to 1.5 V vs. Ag/AgCl for 20 scans at a rate 
of 0.2 V/sec. 
 
 Analysis of PB-22 was conducted in the electrochemical cell at concentrations between 
0.208 µg/mL and 6.7 µg/mL. Differential pulse voltammetry was carried out from 1.8 V. to 0.7 V 
with a step of -0.008 V, modulation amplitude of 0.14 V, modulation time of 0.05 seconds, and an 
interval time of 1 second. The working electrode surface was polished and electrochemically 




Electrochemical measurements were carried out using the Autolab PGSTAT with NOVA 
software from Metrohm (Ionenstrasse, Switzerland). A Millipore Direct-Qâ UV water 
purification system (Billerica, MA) was used to obtain purified water. 
 
1.3.3 Results and Discussion 
 
 The importance of the polishing and cleaning procedure was demonstrated through the 
analysis of replicate concentrations of PB-22. Repeatability was excellent for analysis of samples 
following a thorough cleaning of the working electrode. However, when attempting to analyze 
samples without the cleaning step, the peak heights were not reproducible. The cyclic 
voltammogram for the cleaning procedure can be seen in Figure 46. 
 




Figure 47: Cyclic voltammogram in 0.5 M sulfuric acid for electrochemical cleaning the platinum working 
electrode. 
 
 Electrochemical detection of PB-22 was achieved utilizing a platinum working electrode 
with platinum auxiliary electrode and Ag/AgCl reference electrode. Analysis concentrations were 
achieved through dilution of the previous samples. The differential pulse method utilized yielded 
an observable reduction peak at the lowest concentration of approximately 208 parts-per-billion. 
The average peak height at the lowest concentration was approximately -5.5 x10-7 A. The noise 
was estimated to be between 100-200 nA making the current response between 3 and 5 times the 
noise level. Standard deviation of peak height between replicates was between ~ -3.4 x10-7 A and 
-1.1 x10-6 A for the smallest and largest concentrations, respectively. A standard curve was 
generated that included the largest concentration and had an R2 value of 0.9814. By removing the 
highest concentration, the new R2 value of 0.99955 was achieved (Figure 47). 
 
 
Figure 48: Differential pulse voltammograms for analysis of PB-22 in an electrochemical cell (left) and 
the resulting calibration curve for 3 replicates (right). 















































Detection of the synthetic cannabinoid PB-22 was demonstrated to be achievable utilizing 
the differential pulse method described above. Excellent linearity was achieved for the method 
between ~0.200 µg/mL and 3.33 µg/mL. This method differed from the majority of 
electrochemical methods due to the analysis of the analyte in an organic medium rather than an 
aqueous medium. Future work will entail the detection of other synthetic cannabinoids using both 
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Table A1: Structures of Target Analytes 
Norfentanyl Methoxyacetyl fentanyl Acetyl fentanyl 
 
  








2’-Fluoro ortho-fluorofentanyl U-47700 4-Fluoroisobutyryl fentanyl 
 
  
















































Figure A1: Chromatographic separation of analytes of interest and other illicit drugs. 





















































Figure A4: Adsorptive stripping square-wave voltammograms for the detection of fentanyl at 
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Figure A5: Plots demonstrating response ratio versus time, representing the stability of analytes 

















































































































































































































































































































































































































































































































Figure A6: Plots demonstrating response ratio versus time, representing the stability of analytes 
at both the low and high concentrations over 72 hours at room temperature for autosampler 

































































































































































































































































































































































































































































































High Concentration Valeryl fentanyl





Figure A7: Plots demonstrating response ratio versus time, representing the stability of analytes 



















































































































































































































































































































































































































































































High Concentration Valeryl fentanyl
